HoSeyLiao48的个人主页 - 老虎社区

HoSeyLiao48

HoSeyLiao48

个人简介：Invest! don't be a salaryman.

IP属地：未知

499关注

90粉丝

0主题

0勋章

2021-12-14

ABBV[Allin] [USD] [Call] [Call] [Like]

2 Warren Buffett Dividend Stocks to Buy Right Now

2021-11-29

[冷漠] [可怜] [叹气] [疑问] [心碎]

Merck stock dipped more than 4% in morning trading

2021-11-17

[强] [看涨] [看涨] [梭哈] [美金] [保佑]

Rivian Leaps Past Volkswagen’s Valuation as EV Mania Rages

2021-12-26

[USD] [Allin] [Call] [Like] [Bless]

1 Retail Stock That Can Go Head-to-Head With E-Commerce

2021-12-21

[USD] [Allin] [Like] [Call] [Call]

Apple Stock: If You're Buying the Dip, Here's What You Need to Know

2021-12-15

[Like] [Heart]

Pfizer says COVID-19 pill near 90% protective against hospitalization, death

2021-11-19

[强] [看涨]

Amazon, BofA Could Owe More Under a New Corporate-Minimum Tax

2021-10-12

[强]

Amazon CEO Jassy revises company's return-to-office guidelines

2021-10-12

[强]

Levi’s to Launch Visual Search, Deploy Computer Vision

2021-10-02

[强] [看涨] [看涨] [梭哈] [美金]

Here's Why Smart Investors Are Watching Pinterest Right Now

2021-09-21

[财迷] [强] [看涨] [看涨]

U.S. stocks gain at Tuesday's open

2021-09-07

Can I buy AT&T? Is it the time to go in?[财迷] [得意] [看涨] [看涨] [梭哈] [美金]

Has AT&T Stock Gotten Too Cheap?

2021-08-30

[财迷] [强] [看涨] [看涨] [看涨] [美金] [梭哈]

抱歉，原内容已删除

2021-07-19

Wow didn't get my bullet ready yet[流泪] [捂脸]

Five9 rose more than 10% in premarket trading

2021-09-28

Is there any Pharmaceutical ETF to recommend?[梭哈] [美金]

Pharmaceutical stocks slid in morning trading

2021-09-02

Up up up[强] [看涨] [看涨] [看涨] [美金]

Tech stocks send Nasdaq to fresh record close, boost S&P

2021-07-28

Good buy . Must buy[吃瓜] [哇塞]

Apple, AMD navigate chip shortage with focus on profitable products

2021-07-25

How about Etsy? [疑问] [思考]

抱歉，原内容已删除

2021-12-13

[Allin] [USD] [Call] [Call] [Call] [Like] [Like] [Bless] [Miser]

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4087949413245130,"uuid":"4087949413245130","gmtCreate":1624846350082,"gmtModify":1639150209550,"name":"HoSeyLiao48","pinyin":"hoseyliao48","introduction":"","introductionEn":null,"signature":"Invest! don't be a salaryman.","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":90,"headSize":499,"tweetSize":155,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":692663310,"gmtCreate":1640943476833,"gmtModify":1640943725107,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Allin]&nbsp;[USD]&nbsp;[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;","listText":"[Allin]&nbsp;[USD]&nbsp;[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;","text":"[Allin] [USD] [Like] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692663310","repostId":"1136134075","repostType":4,"repost":{"id":"1136134075","pubTimestamp":1640939937,"share":"https://www.laohu8.com/m/news/1136134075?lang=&edition=full","pubTime":"2021-12-31 16:38","market":"us","language":"en","title":"2 Stocks Under $100 You Can Buy and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=1136134075","media":"Motley Fool","summary":"You don't have to be a millionaire -- or even a thousandaire -- to buy these two veteran companies with bright futures.","content":"<html><head></head><body><p>We&#39;re riding along with one of the longest bull markets in history. As a consequence, many good stocks have seen their prices shoot up well into the triple -- and even quadruple -- digits.</p><p>But there are plenty of quality titles out there that don&#39;t require spending half of a monthly salary to own. Here is a pair of stocks that are not only worthwhile today, but will likely reward their owners for a great many years to come:<b>Coca-Cola</b>(NYSE:KO) and <b>Verizon Communications</b>(NYSE:VZ).</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a5642f2b7e33e89a6d618731ad04d872\" tg-width=\"2000\" tg-height=\"1334\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>1. Coca-Cola</b></p><p>Coke is a classic American company that has been a favorite blue-chip stock for many investors over the years. It&#39;s no wonder -- even in challenging times, the company always finds a way to earn a buck and amass mountains of cash.</p><p>These certainly qualify as challenging times for Coke. The coronavirus pandemic has wreaked havoc with a great many businesses, including restaurants, a key customer base for the company. Meanwhile, in a long-tail trend that shows little sign of abating, consumers around the world are demanding healthier choices in the food and beverages they buy and consume.</p><p>But the ever-enduring company is still managing to turn a mighty profit despite these considerable headwinds -- and has even posted some top-line growth of late. Coke&#39;s third quarter saw it lift net revenue a sturdy 16% to over $10 billion, helped by consumers returning to restaurants (before the omicron variant emerged). Consolidated net income leaped 42% higher to nearly $2.5 billion.</p><p>Impressively, that represents a 20%-plus net profit margin, illustrating an important part of Coke&#39;s lasting appeal: its durable and strong profitability. There&#39;s a reason it&#39;s been a favorite holding of many successful investors. Among these is Warren Buffett, whose <b>Berkshire Hathaway</b> has held a large Coke position since 1988.</p><p>Another big part of Coke&#39;s appeal is its dividend, which is one of the steadiest and most reliable on the market. The company has not only been doling it out with comforting regularity for decades; it&#39;s actually a Dividend King. And Coca-Cola is not chintzy with the payout -- at the most recent share price, the stock yielded nearly 2.9%, a very respectable figure when matched against many other blue-chip stock distributions.</p><p><b>2. Verizon</b></p><p>Verizon is a leader in the telecom sector that didn&#39;t get a lot of love from Mr. Market in 2021. Several top- and bottom-line misses across the year&#39;s quarters badly affected investor sentiment. Meanwhile, investors tended to favor other tech titles seen to be better plays, either on the coronavirus or the anticipated post-pandemic recovery.</p><p>The company didn&#39;t deserve to be punished like that. After all, in each of the last three reported quarters, Verizon has managed decent growth in both revenue and net profit despite the aforementioned misses. Notably, at times those two line items were higher not only when compared to pandemic-blighted 2020, but also to pre-coronavirus 2019.</p><p>Investor disfavor has pushed Verizon down into bargain stock territory; its forward price-to-earnings ratio is a ridiculous 9.3. Meanwhile the company has been plowing money into building out its 5G network, an effort that should pay off handsomely in the coming years if it can become the leader in that attractive technology. Customers are already snapping up new(ish) 5G-capable devices at an impressive clip, a trend that&#39;ll help boost growth.</p><p>Speaking of those customers, there are around 95 million retail connections on Verizon&#39;s network. That equates to heavy and regular cash flow. Verizon is clearly dedicated to using much of this for a shareholder dividend, one that it&#39;s paid since before it was called Verizon (it was previously Bell Atlantic -- for you corporate trivia buffs). And from 2007, that payout has seen a raise once every year.</p><p>Those constant increases, combined with the sagging share price, has made for quite a hefty dividend yield -- 4.9% at the most recent closing stock price. So with Verizon we&#39;ve got a nice runway for growth, a cheap stock price, a high dividend yield -- all layered on top of a business that millions of customers will be using regularly well into the foreseeable future.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Stocks Under $100 You Can Buy and Hold Forever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Stocks Under $100 You Can Buy and Hold Forever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 16:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/30/2-stocks-under-100-you-can-buy-and-hold-forever/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're riding along with one of the longest bull markets in history. As a consequence, many good stocks have seen their prices shoot up well into the triple -- and even quadruple -- digits.But there ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/30/2-stocks-under-100-you-can-buy-and-hold-forever/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VZ":"威瑞森","KO":"可口可乐"},"source_url":"https://www.fool.com/investing/2021/12/30/2-stocks-under-100-you-can-buy-and-hold-forever/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136134075","content_text":"We're riding along with one of the longest bull markets in history. As a consequence, many good stocks have seen their prices shoot up well into the triple -- and even quadruple -- digits.But there are plenty of quality titles out there that don't require spending half of a monthly salary to own. Here is a pair of stocks that are not only worthwhile today, but will likely reward their owners for a great many years to come:Coca-Cola(NYSE:KO) and Verizon Communications(NYSE:VZ).IMAGE SOURCE: GETTY IMAGES.1. Coca-ColaCoke is a classic American company that has been a favorite blue-chip stock for many investors over the years. It's no wonder -- even in challenging times, the company always finds a way to earn a buck and amass mountains of cash.These certainly qualify as challenging times for Coke. The coronavirus pandemic has wreaked havoc with a great many businesses, including restaurants, a key customer base for the company. Meanwhile, in a long-tail trend that shows little sign of abating, consumers around the world are demanding healthier choices in the food and beverages they buy and consume.But the ever-enduring company is still managing to turn a mighty profit despite these considerable headwinds -- and has even posted some top-line growth of late. Coke's third quarter saw it lift net revenue a sturdy 16% to over $10 billion, helped by consumers returning to restaurants (before the omicron variant emerged). Consolidated net income leaped 42% higher to nearly $2.5 billion.Impressively, that represents a 20%-plus net profit margin, illustrating an important part of Coke's lasting appeal: its durable and strong profitability. There's a reason it's been a favorite holding of many successful investors. Among these is Warren Buffett, whose Berkshire Hathaway has held a large Coke position since 1988.Another big part of Coke's appeal is its dividend, which is one of the steadiest and most reliable on the market. The company has not only been doling it out with comforting regularity for decades; it's actually a Dividend King. And Coca-Cola is not chintzy with the payout -- at the most recent share price, the stock yielded nearly 2.9%, a very respectable figure when matched against many other blue-chip stock distributions.2. VerizonVerizon is a leader in the telecom sector that didn't get a lot of love from Mr. Market in 2021. Several top- and bottom-line misses across the year's quarters badly affected investor sentiment. Meanwhile, investors tended to favor other tech titles seen to be better plays, either on the coronavirus or the anticipated post-pandemic recovery.The company didn't deserve to be punished like that. After all, in each of the last three reported quarters, Verizon has managed decent growth in both revenue and net profit despite the aforementioned misses. Notably, at times those two line items were higher not only when compared to pandemic-blighted 2020, but also to pre-coronavirus 2019.Investor disfavor has pushed Verizon down into bargain stock territory; its forward price-to-earnings ratio is a ridiculous 9.3. Meanwhile the company has been plowing money into building out its 5G network, an effort that should pay off handsomely in the coming years if it can become the leader in that attractive technology. Customers are already snapping up new(ish) 5G-capable devices at an impressive clip, a trend that'll help boost growth.Speaking of those customers, there are around 95 million retail connections on Verizon's network. That equates to heavy and regular cash flow. Verizon is clearly dedicated to using much of this for a shareholder dividend, one that it's paid since before it was called Verizon (it was previously Bell Atlantic -- for you corporate trivia buffs). And from 2007, that payout has seen a raise once every year.Those constant increases, combined with the sagging share price, has made for quite a hefty dividend yield -- 4.9% at the most recent closing stock price. So with Verizon we've got a nice runway for growth, a cheap stock price, a high dividend yield -- all layered on top of a business that millions of customers will be using regularly well into the foreseeable future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":631,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696507851,"gmtCreate":1640726058673,"gmtModify":1640726059530,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Like]&nbsp;[Call]&nbsp;","listText":"[Like]&nbsp;[Call]&nbsp;","text":"[Like] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696507851","repostId":"1172682878","repostType":4,"repost":{"id":"1172682878","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640704390,"share":"https://www.laohu8.com/m/news/1172682878?lang=&edition=full","pubTime":"2021-12-28 23:13","market":"us","language":"en","title":"Blockchain Stocks Dropped in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1172682878","media":"Tiger Newspress","summary":"Blockchain stocks dropped in morning trading.Marathon Digital, Bit Digital, Riot Blockchain, Coinbas","content":"<p>Blockchain stocks dropped in morning trading.Marathon Digital,&nbsp;Bit&nbsp;Digital,&nbsp;Riot Blockchain,&nbsp;Coinbase,&nbsp;Canaan,&nbsp;SOS Ltd&nbsp;and&nbsp;Ebang International&nbsp;fell&nbsp;between 3% and 8%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d11548e5ec535c997a2f86f9c063122\" tg-width=\"416\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blockchain Stocks Dropped in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlockchain Stocks Dropped in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 23:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Blockchain stocks dropped in morning trading.Marathon Digital,&nbsp;Bit&nbsp;Digital,&nbsp;Riot Blockchain,&nbsp;Coinbase,&nbsp;Canaan,&nbsp;SOS Ltd&nbsp;and&nbsp;Ebang International&nbsp;fell&nbsp;between 3% and 8%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d11548e5ec535c997a2f86f9c063122\" tg-width=\"416\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BTBT":"Bit Digital, Inc.","SOS":"SOS Limited","EBON":"亿邦国际","CAN":"嘉楠科技","RIOT":"Riot Platforms","MARA":"Marathon Digital Holdings Inc","COIN":"Coinbase Global, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172682878","content_text":"Blockchain stocks dropped in morning trading.Marathon Digital, Bit Digital, Riot Blockchain, Coinbase, Canaan, SOS Ltd and Ebang International fell between 3% and 8%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":759,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696145278,"gmtCreate":1640655217518,"gmtModify":1640655218463,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Like]&nbsp;","listText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Like]&nbsp;","text":"[Allin] [USD] [Call] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696145278","repostId":"1156481741","repostType":4,"repost":{"id":"1156481741","pubTimestamp":1640652473,"share":"https://www.laohu8.com/m/news/1156481741?lang=&edition=full","pubTime":"2021-12-28 08:47","market":"us","language":"en","title":"Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?","url":"https://stock-news.laohu8.com/highlight/detail?id=1156481741","media":"Investors","summary":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Me","content":"<p>The Food and Drug Administration authorized&nbsp;<b>Merck</b>'s (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.</p>\n<p>The FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.<b>Pfizer</b>(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.</p>\n<p>Merck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.</p>\n<p>Merck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.</p>\n<p>Merck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.</p>\n<p>So, all in all, is Merck stock a buy or a sell right now?</p>\n<p><b>Merck Stock Fundamentals: Sales Top</b></p>\n<p>During the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.</p>\n<p>Merck also provided guidance following its&nbsp;<b>Organon</b>(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.</p>\n<p>The company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.</p>\n<p>But revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.</p>\n<p>Overall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.</p>\n<p>In the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.</p>\n<p><b>What Do Annual Metrics Say About Merck?</b></p>\n<p>As Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.</p>\n<p>Last year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.</p>\n<p>For 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.</p>\n<p>The stock ranks 6th by&nbsp;Composite Rating&nbsp;in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.</p>\n<p><b>Technical Analysis Of The Pharmaceutical Company</b></p>\n<p>Merck stock has a&nbsp;Composite Rating&nbsp;of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.</p>\n<p>Shares also have a&nbsp;Relative Strength Rating&nbsp;of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.</p>\n<p>It's also key to watch chart patterns. Merck stock broke out of a&nbsp;flat base&nbsp;with abuy point&nbsp;at 79.33 on Oct. 1, according to&nbsp;MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are&nbsp;encouraged to sell&nbsp;when a stock is 7%-8% below its entry.</p>\n<p>Merck stock also recently undercut its&nbsp;50-day&nbsp;and&nbsp;200-day&nbsp;moving averages. Both are sell signals.</p>\n<p><b>Merck Stock News: Merck Grabs Covid Deal</b></p>\n<p>Merck's molnupiravir is now authorized in the U.S., U.K. and Japan.</p>\n<p>In addition to Merck and Pfizer,<b>Atea Pharmaceuticals</b>(AVIR) and&nbsp;<b>Enanta Pharmaceuticals</b>(ENTA) working on oral Covid drugs.<b>Roche</b>(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.</p>\n<p>Analysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from&nbsp;<b>Regeneron Pharmaceuticals</b>(REGN),<b>Eli Lilly</b>(LLY) and&nbsp;<b>Vir Biotechnology</b>(VIR). Antibody drugs must be given by health care professionals.</p>\n<p>But there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.</p>\n<p>Bearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and&nbsp;<b>Gilead Sciences</b>(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.</p>\n<p>Merck also recently finished acquiring Acceleron.</p>\n<p>In early March, President Joe Biden announced Merck would help<b>Johnson &amp; Johnson</b>(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.</p>\n<p><b>Is Merck Stock A Buy Now?</b></p>\n<p>Based on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.</p>\n<p>There are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.</p>\n<p>Still, big stocks like Merck can add gains without hitting massive growth streaks.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220><strong>Investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill ...</p>\n\n<a href=\"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156481741","content_text":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.Pfizer(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.\nMerck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.\nMerck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.\nMerck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.\nSo, all in all, is Merck stock a buy or a sell right now?\nMerck Stock Fundamentals: Sales Top\nDuring the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.\nMerck also provided guidance following its Organon(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.\nThe company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.\nBut revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.\nOverall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.\nIn the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.\nWhat Do Annual Metrics Say About Merck?\nAs Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.\nLast year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.\nFor 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.\nThe stock ranks 6th by Composite Rating in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.\nTechnical Analysis Of The Pharmaceutical Company\nMerck stock has a Composite Rating of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.\nShares also have a Relative Strength Rating of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.\nIt's also key to watch chart patterns. Merck stock broke out of a flat base with abuy point at 79.33 on Oct. 1, according to MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are encouraged to sell when a stock is 7%-8% below its entry.\nMerck stock also recently undercut its 50-day and 200-day moving averages. Both are sell signals.\nMerck Stock News: Merck Grabs Covid Deal\nMerck's molnupiravir is now authorized in the U.S., U.K. and Japan.\nIn addition to Merck and Pfizer,Atea Pharmaceuticals(AVIR) and Enanta Pharmaceuticals(ENTA) working on oral Covid drugs.Roche(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.\nAnalysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from Regeneron Pharmaceuticals(REGN),Eli Lilly(LLY) and Vir Biotechnology(VIR). Antibody drugs must be given by health care professionals.\nBut there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.\nBearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and Gilead Sciences(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.\nMerck also recently finished acquiring Acceleron.\nIn early March, President Joe Biden announced Merck would helpJohnson & Johnson(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.\nIs Merck Stock A Buy Now?\nBased on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.\nThere are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.\nStill, big stocks like Merck can add gains without hitting massive growth streaks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698544852,"gmtCreate":1640480395781,"gmtModify":1640480396640,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[USD]&nbsp;[Allin]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","listText":"[USD]&nbsp;[Allin]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","text":"[USD] [Allin] [Call] [Like] [Bless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698544852","repostId":"2194171798","repostType":4,"repost":{"id":"2194171798","pubTimestamp":1640480255,"share":"https://www.laohu8.com/m/news/2194171798?lang=&edition=full","pubTime":"2021-12-26 08:57","market":"us","language":"en","title":"1 Retail Stock That Can Go Head-to-Head With E-Commerce","url":"https://stock-news.laohu8.com/highlight/detail?id=2194171798","media":"Motley Fool","summary":"This company aced its pivot to omnichannel retail.","content":"<p>It wasn't too long ago that <b>Best Buy</b>'s (NYSE:BBY) viability was in doubt. E-commerce retailers like <b>Amazon</b> (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up well to compete. In this <i>Fool Live</i> video clip,&nbsp;<b>recorded on Dec. 13,&nbsp;</b>Fool.com contributors Jason Hall and Danny Vena discuss Best Buy's impressive transformation and what could be ahead.</p>\n<p><b>Jason Hall:</b> This company is an absolute survivor. You go back to the early 2000s when Best Buy was really just emerging as a national player. What a lot of people don't know is that the company almost got put out of business for bait-and-switch tactics because they had a high-pressure commission salesforce, and they were baiting and switching. And the company, they still deny that, but the reality is that's what they were doing.</p>\n<p>They came away from it, they dropped their entire sales staff to hourly, changed the model completely. Coincided with the birth of the internet and people not really needing to find a salesperson to explain the difference between two dryers anymore -- that's what the internet is for. They revolutionized their business and went on a 10-year raging growth path. Then the internet started to become the enemy of the business, as Matt was talking about. Then they were able to pivot with their omnichannel. That's worked really well.</p>\n<p>I think just right now, they're dealing with the fact that everything they sell has a semiconductor in it. There's not enough of those around anymore. If that's a problem in the near term. But I think it's an opportunity in the long term because everything they sell has a semiconductor in it, that means they are selling the things that people want. I think it fits right in the middle of this pack. It's a good, strong business. It's a survivor, probably not a market beater, market killer anyway, probably a run-at-market-perform business. But I think it's pretty well positioned.</p>\n<p><b>Danny Vena:</b> Yes, this is a company that I voted probably the high end of middle of the pack. I voted this No. 4 [out of 10 \"holiday shopping\" stocks]. For me, I think one of the more overlooked things about Best Buy, and I absolutely agree with everything that Jason said and the fact that the company has done remarkably well at doing the omnichannel business during the pandemic. They had folks order stuff online, pickup in store so they could get it right away. They were able to tap into that remote work from home, trends that happened.</p>\n<p>I think one of the most overlooked things about what Best Buy has done is they have introduced essentially a subscription program. They already had one where you could pay $199 a year and you could bring in your computer and have them diagnosis it. They could add software, they could do a lot of things. Now, they have changed that to where you get unlimited calls with Geek Squad. They will help you with essentially anything having to do with electronics. That I think is going to be a high-margin business. I think it's going to lift their margins. I think it gives them an opportunity to keep their brand front of mind with consumers.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Retail Stock That Can Go Head-to-Head With E-Commerce</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Retail Stock That Can Go Head-to-Head With E-Commerce\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 08:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It wasn't too long ago that Best Buy's (NYSE:BBY) viability was in doubt. E-commerce retailers like Amazon (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4548":"巴美列捷福持仓","BK4532":"文艺复兴科技持仓","BBY":"百思买","BK4554":"元宇宙及AR概念","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4550":"红杉资本持仓","BK4076":"电脑与电子产品零售","AMZN":"亚马逊","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194171798","content_text":"It wasn't too long ago that Best Buy's (NYSE:BBY) viability was in doubt. E-commerce retailers like Amazon (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up well to compete. In this Fool Live video clip, recorded on Dec. 13, Fool.com contributors Jason Hall and Danny Vena discuss Best Buy's impressive transformation and what could be ahead.\nJason Hall: This company is an absolute survivor. You go back to the early 2000s when Best Buy was really just emerging as a national player. What a lot of people don't know is that the company almost got put out of business for bait-and-switch tactics because they had a high-pressure commission salesforce, and they were baiting and switching. And the company, they still deny that, but the reality is that's what they were doing.\nThey came away from it, they dropped their entire sales staff to hourly, changed the model completely. Coincided with the birth of the internet and people not really needing to find a salesperson to explain the difference between two dryers anymore -- that's what the internet is for. They revolutionized their business and went on a 10-year raging growth path. Then the internet started to become the enemy of the business, as Matt was talking about. Then they were able to pivot with their omnichannel. That's worked really well.\nI think just right now, they're dealing with the fact that everything they sell has a semiconductor in it. There's not enough of those around anymore. If that's a problem in the near term. But I think it's an opportunity in the long term because everything they sell has a semiconductor in it, that means they are selling the things that people want. I think it fits right in the middle of this pack. It's a good, strong business. It's a survivor, probably not a market beater, market killer anyway, probably a run-at-market-perform business. But I think it's pretty well positioned.\nDanny Vena: Yes, this is a company that I voted probably the high end of middle of the pack. I voted this No. 4 [out of 10 \"holiday shopping\" stocks]. For me, I think one of the more overlooked things about Best Buy, and I absolutely agree with everything that Jason said and the fact that the company has done remarkably well at doing the omnichannel business during the pandemic. They had folks order stuff online, pickup in store so they could get it right away. They were able to tap into that remote work from home, trends that happened.\nI think one of the most overlooked things about what Best Buy has done is they have introduced essentially a subscription program. They already had one where you could pay $199 a year and you could bring in your computer and have them diagnosis it. They could add software, they could do a lot of things. Now, they have changed that to where you get unlimited calls with Geek Squad. They will help you with essentially anything having to do with electronics. That I think is going to be a high-margin business. I think it's going to lift their margins. I think it gives them an opportunity to keep their brand front of mind with consumers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691287008,"gmtCreate":1640207585794,"gmtModify":1640207586676,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;[Bless]&nbsp;","listText":"[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;[Bless]&nbsp;","text":"[Like] [Call] [Call] [Bless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691287008","repostId":"1122126959","repostType":4,"repost":{"id":"1122126959","pubTimestamp":1640186098,"share":"https://www.laohu8.com/m/news/1122126959?lang=&edition=full","pubTime":"2021-12-22 23:14","market":"us","language":"en","title":"Apple iPhone production may surprise to upside, Morgan Stanley says","url":"https://stock-news.laohu8.com/highlight/detail?id=1122126959","media":"seekingalpha","summary":"Apple(NASDAQ:AAPL)iPhone production could surprise to the upside this quarter, Morgan Stanley analys","content":"<p>Apple(NASDAQ:AAPL)iPhone production could surprise to the upside this quarter, Morgan Stanley analyst Katy Huberty wrote in a note to clients, as lead times are declining to \"more normalized levels.\"</p>\n<p>Citing a \"handful\" of data points that the firm has seen over the past month, Huberty notes that the supply of semi-related components are improving and iPhone builds in the December quarter are \"stable\" at 82 million units. In addition, Apple (AAPL) is seeing improved supply for power management integrated circuits and world-facing camera modules, all of which suggests that iPhone builds in December are likely to be flat or slightly down month-over-month, compared to a significant month-over-month decline in previous years.</p>\n<p>Additionally, Huberty notes that lead times for Apple's (AAPL) high-end iPhone 13 models, the Pro and Pro Max are at 2 days as of December 21, down from 20 days a month ago.</p>\n<p>'[W]hile some investors may view this lead time contraction as a sign of slowing demand, we'd note that major end markets like China are posting iPhone shipment growth of +46% [year-over-year] [quarter-to-date] through the end of November,\" Huberty wrote.</p>\n<p>\"While we don't have enough data to definitively say that iPhone will exit the December quarter in supply/demand balance, we do believe that iPhone production is surprising to the upside, which supports our 7% above consensus December quarter iPhone revenue forecast.\"</p>\n<p>Apple (AAPL) shares have&nbsp;gained more than 33% year-to-date.</p>\n<p>Huberty added that she is keeping an eye on Apple (AAPL) retail stores that are closing as a result of increasing COVID-19 cases in North America.</p>\n<p>On Tuesday, Apple (AAPL) was upgraded at Moody's, as the credit-ratings agency&nbsp;cited the tech giant's \"exceptional liquidity\" and earnings power.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple iPhone production may surprise to upside, Morgan Stanley says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple iPhone production may surprise to upside, Morgan Stanley says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 23:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3782708-apple-iphone-production-may-surprise-to-upside-morgan-stanley-says><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple(NASDAQ:AAPL)iPhone production could surprise to the upside this quarter, Morgan Stanley analyst Katy Huberty wrote in a note to clients, as lead times are declining to \"more normalized levels.\"\n...</p>\n\n<a href=\"https://seekingalpha.com/news/3782708-apple-iphone-production-may-surprise-to-upside-morgan-stanley-says\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/news/3782708-apple-iphone-production-may-surprise-to-upside-morgan-stanley-says","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122126959","content_text":"Apple(NASDAQ:AAPL)iPhone production could surprise to the upside this quarter, Morgan Stanley analyst Katy Huberty wrote in a note to clients, as lead times are declining to \"more normalized levels.\"\nCiting a \"handful\" of data points that the firm has seen over the past month, Huberty notes that the supply of semi-related components are improving and iPhone builds in the December quarter are \"stable\" at 82 million units. In addition, Apple (AAPL) is seeing improved supply for power management integrated circuits and world-facing camera modules, all of which suggests that iPhone builds in December are likely to be flat or slightly down month-over-month, compared to a significant month-over-month decline in previous years.\nAdditionally, Huberty notes that lead times for Apple's (AAPL) high-end iPhone 13 models, the Pro and Pro Max are at 2 days as of December 21, down from 20 days a month ago.\n'[W]hile some investors may view this lead time contraction as a sign of slowing demand, we'd note that major end markets like China are posting iPhone shipment growth of +46% [year-over-year] [quarter-to-date] through the end of November,\" Huberty wrote.\n\"While we don't have enough data to definitively say that iPhone will exit the December quarter in supply/demand balance, we do believe that iPhone production is surprising to the upside, which supports our 7% above consensus December quarter iPhone revenue forecast.\"\nApple (AAPL) shares have gained more than 33% year-to-date.\nHuberty added that she is keeping an eye on Apple (AAPL) retail stores that are closing as a result of increasing COVID-19 cases in North America.\nOn Tuesday, Apple (AAPL) was upgraded at Moody's, as the credit-ratings agency cited the tech giant's \"exceptional liquidity\" and earnings power.","news_type":1},"isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693498078,"gmtCreate":1640057094513,"gmtModify":1640057928006,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[USD]&nbsp;[Allin]&nbsp;[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;","listText":"[USD]&nbsp;[Allin]&nbsp;[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;","text":"[USD] [Allin] [Like] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693498078","repostId":"1112391676","repostType":4,"isVote":1,"tweetType":1,"viewCount":556,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607894148,"gmtCreate":1639522772006,"gmtModify":1639522772840,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Like]&nbsp;[Heart]&nbsp;","listText":"[Like]&nbsp;[Heart]&nbsp;","text":"[Like] [Heart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607894148","repostId":"2191937155","repostType":4,"repost":{"id":"2191937155","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639521474,"share":"https://www.laohu8.com/m/news/2191937155?lang=&edition=full","pubTime":"2021-12-15 06:37","market":"us","language":"en","title":"Pfizer says COVID-19 pill near 90% protective against hospitalization, death","url":"https://stock-news.laohu8.com/highlight/detail?id=2191937155","media":"Reuters","summary":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% ","content":"<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says COVID-19 pill near 90% protective against hospitalization, death</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says COVID-19 pill near 90% protective against hospitalization, death\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BK4007":"制药","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191937155","content_text":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.\nThe U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.\nNobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.\nThe Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.\n\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.\n\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.\nPfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.\nPfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.\nDolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.\n\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.\n'VERY EXCITING RESULTS'\nPfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.\nPaxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS\n\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.\nSax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.\nThere are currently no oral antiviral treatments for COVID-9 authorized in the United States.\nAnalysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.\nRival Merck & Co has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.\nSome scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.\nPfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.\nRecent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.\nThe company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.\nDolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.\nPfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.\nThe MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.\nThe U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":706,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607365077,"gmtCreate":1639491666213,"gmtModify":1639491717114,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"ABBV[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;","listText":"ABBV[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;","text":"ABBV[Allin] [USD] [Call] [Call] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607365077","repostId":"2191930972","repostType":4,"repost":{"id":"2191930972","pubTimestamp":1639489168,"share":"https://www.laohu8.com/m/news/2191930972?lang=&edition=full","pubTime":"2021-12-14 21:39","market":"us","language":"en","title":"2 Warren Buffett Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191930972","media":"Motley Fool","summary":"AbbVie and Royalty Pharma should be on every dividend investor's radar right now.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.</p>\n<p>As a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.</p>\n<p>Which Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks <b>AbbVie</b> (NYSE:ABBV) and <b>Royalty Pharma</b> (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.</p>\n<h2>AbbVie: A high-yield growth stock</h2>\n<p>Berkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest yields among major drug manufacturers.</p>\n<p>Second, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.</p>\n<p>Lastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.</p>\n<p>The net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.</p>\n<h2>Royalty Pharma: A dependable revenue stream</h2>\n<p>Royalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.</p>\n<p><img src=\"https://static.tigerbbs.com/a320f51af9bb7ac0d6359af7ed64161a\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>RPRX data by YCharts</p>\n<p>Why is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.</p>\n<p>Now, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Dividend Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Dividend Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BRK.A":"伯克希尔","BK4007":"制药","RPRX":"Royalty Pharma plc","BRK.B":"伯克希尔B","BK4566":"资本集团","BK4139":"生物科技","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BK4176":"多领域控股"},"source_url":"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191930972","content_text":"Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.\nAs a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.\nWhich Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks AbbVie (NYSE:ABBV) and Royalty Pharma (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.\nAbbVie: A high-yield growth stock\nBerkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's one of the highest yields among major drug manufacturers.\nSecond, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.\nLastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.\nThe net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.\nRoyalty Pharma: A dependable revenue stream\nRoyalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.\n\nRPRX data by YCharts\nWhy is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.\nNow, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.","news_type":1},"isVote":1,"tweetType":1,"viewCount":606,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604790586,"gmtCreate":1639443801909,"gmtModify":1639443802723,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Allin]&nbsp;[USD]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","listText":"[Allin]&nbsp;[USD]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","text":"[Allin] [USD] [USD] [Call] [Call] [Like] [Bless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604790586","repostId":"2191698116","repostType":4,"repost":{"id":"2191698116","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639441679,"share":"https://www.laohu8.com/m/news/2191698116?lang=&edition=full","pubTime":"2021-12-14 08:27","market":"us","language":"en","title":"Intel's first foray into the metaverse will be software to use others' chips","url":"https://stock-news.laohu8.com/highlight/detail?id=2191698116","media":"Reuters","summary":"Dec 13 (Reuters) - In their first public comments on its strategy for tapping into the \"metaverse,\" ","content":"<p>Dec 13 (Reuters) - In their first public comments on its strategy for tapping into the \"metaverse,\" Intel Corp&nbsp;executives said the firm is working on software that will help laptops tap into computing power from other devices, including chips from its rivals.</p>\n<p>While the definition of \"metaverse\" is broad, it generally refers to immersive virtual worlds that will be accessed via the internet and a variety of devices, like virtual reality headsets.</p>\n<p>The trend is expected to require vastly more computing power, and firms like Nvidia Corp, which makes chips and software used to construct the virtual world, and Qualcomm Inc, which makes chips used in virtual reality headsets, have both gained value in recent months on investor enthusiasm about the metaverse.</p>\n<p>At a news conference after a presentation at the RealTime Conference on metaverse technologies on Monday, Raja Koduri, head of Intel's accelerated computing systems and graphics group, said the company's first technology push into the metaverse will be software that helps devices take advantage of computing power that already exists and is unused.</p>\n<p>For example, if a gamer is playing a graphics-heavy title on a laptop that would tax the system's chips but has an unused gaming PC in another room, the software could detect the spare power sitting idle on the PC and tap into it over a home network to make the laptop game run better.</p>\n<p>Koduri said the software will work with chips from competitors. The software is designed to solve technical challenges for users, and not just to generate major revenue for Intel. Some of it will be shared, Koduri said.</p>\n<p>\"The way we are architecting all the layers is that it is going to work with everybody's hardware, as long as they are on industry standard specifications,\" Koduri told reporters. \"There'll be a lot of open sourcing involved with everything that we build.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel's first foray into the metaverse will be software to use others' chips</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel's first foray into the metaverse will be software to use others' chips\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-14 08:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 13 (Reuters) - In their first public comments on its strategy for tapping into the \"metaverse,\" Intel Corp&nbsp;executives said the firm is working on software that will help laptops tap into computing power from other devices, including chips from its rivals.</p>\n<p>While the definition of \"metaverse\" is broad, it generally refers to immersive virtual worlds that will be accessed via the internet and a variety of devices, like virtual reality headsets.</p>\n<p>The trend is expected to require vastly more computing power, and firms like Nvidia Corp, which makes chips and software used to construct the virtual world, and Qualcomm Inc, which makes chips used in virtual reality headsets, have both gained value in recent months on investor enthusiasm about the metaverse.</p>\n<p>At a news conference after a presentation at the RealTime Conference on metaverse technologies on Monday, Raja Koduri, head of Intel's accelerated computing systems and graphics group, said the company's first technology push into the metaverse will be software that helps devices take advantage of computing power that already exists and is unused.</p>\n<p>For example, if a gamer is playing a graphics-heavy title on a laptop that would tax the system's chips but has an unused gaming PC in another room, the software could detect the spare power sitting idle on the PC and tap into it over a home network to make the laptop game run better.</p>\n<p>Koduri said the software will work with chips from competitors. The software is designed to solve technical challenges for users, and not just to generate major revenue for Intel. Some of it will be shared, Koduri said.</p>\n<p>\"The way we are architecting all the layers is that it is going to work with everybody's hardware, as long as they are on industry standard specifications,\" Koduri told reporters. \"There'll be a lot of open sourcing involved with everything that we build.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QCOM":"高通","INTC":"英特尔"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191698116","content_text":"Dec 13 (Reuters) - In their first public comments on its strategy for tapping into the \"metaverse,\" Intel Corp executives said the firm is working on software that will help laptops tap into computing power from other devices, including chips from its rivals.\nWhile the definition of \"metaverse\" is broad, it generally refers to immersive virtual worlds that will be accessed via the internet and a variety of devices, like virtual reality headsets.\nThe trend is expected to require vastly more computing power, and firms like Nvidia Corp, which makes chips and software used to construct the virtual world, and Qualcomm Inc, which makes chips used in virtual reality headsets, have both gained value in recent months on investor enthusiasm about the metaverse.\nAt a news conference after a presentation at the RealTime Conference on metaverse technologies on Monday, Raja Koduri, head of Intel's accelerated computing systems and graphics group, said the company's first technology push into the metaverse will be software that helps devices take advantage of computing power that already exists and is unused.\nFor example, if a gamer is playing a graphics-heavy title on a laptop that would tax the system's chips but has an unused gaming PC in another room, the software could detect the spare power sitting idle on the PC and tap into it over a home network to make the laptop game run better.\nKoduri said the software will work with chips from competitors. The software is designed to solve technical challenges for users, and not just to generate major revenue for Intel. Some of it will be shared, Koduri said.\n\"The way we are architecting all the layers is that it is going to work with everybody's hardware, as long as they are on industry standard specifications,\" Koduri told reporters. \"There'll be a lot of open sourcing involved with everything that we build.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604887616,"gmtCreate":1639370780443,"gmtModify":1639370781295,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;[Like]&nbsp;[Bless]&nbsp;[Miser]&nbsp;","listText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;[Like]&nbsp;[Bless]&nbsp;[Miser]&nbsp;","text":"[Allin] [USD] [Call] [Call] [Call] [Like] [Like] [Bless] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604887616","repostId":"1175891189","repostType":2,"repost":{"id":"1175891189","pubTimestamp":1639354864,"share":"https://www.laohu8.com/m/news/1175891189?lang=&edition=full","pubTime":"2021-12-13 08:21","market":"us","language":"en","title":"2 Reasons To Own Apple Stock in 2022: iPhone, Apple Glass","url":"https://stock-news.laohu8.com/highlight/detail?id=1175891189","media":"TheStreet","summary":"As 2021 draws close to an end, investors seem confident that Apple stock will continue to perform st","content":"<p>As 2021 draws close to an end, investors seem confident that Apple stock will continue to perform strongly into the new year. Here are two reasons why they may be right.</p>\n<p>Wall Street analysts continue to debate whether Apple stock&nbsp;is a buy as we head into 2022. Recently,I presented the bear argument&nbsp;that, if proven right, could foretell a drop of around 18% in the stock price.</p>\n<p>But investors seem to be siding with bulls at the moment, as AAPL shares continue to make fresh highs. Today, I talk about two key reasons recently presented by analysts suggesting that Apple stock could be a good bet for the new year.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c2e0accd2eec6d8660139f01d4786050\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple's iPhone 13, Apple Watch and AirPods Pro.</span></p>\n<p><b>iPhone: not all about the holiday</b></p>\n<p>The recent headlines have highlighted&nbsp;the expected performance of the iPhone&nbsp;in the current holiday period. Bloomberg hinted at a slowdown in demand, supported by alleged order cancellations with suppliers. The data point&nbsp;contradicted earlier Wall Street projections&nbsp;for an above-estimate volume of iPhone shipments in the current shopping season.</p>\n<p>But DigiTimes Taiwan has recently&nbsp;shifted&nbsp;the focus of attention to the longer term. According to the publication, Apple is looking to “[increase] iPhone shipments by 30% for the first half of next year with the larger goal of exceeding 300 million iPhone shipments in 2022.”</p>\n<p>If confirmed, this would represent massive YOY improvement, especially in the first few months of the year. Keep in mind (chart below) that the Cupertino company dropped the mic on iPhone sales in the early part of 2021, setting the bar very high for growth in 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee90d77969b11205181863715e8ab4f1\" tg-width=\"784\" tg-height=\"544\" width=\"100%\" height=\"auto\"><span>Figure 2: iPhone revenue growth since F19.</span></p>\n<p>I would warn readers, however, not to rely too much on unofficial announcements about iPhone sales. In addition to the issue of reliability of rumors, the assumption of higher shipments could be a misread on Apple ramping up iPhone production to anticipate supply chain constraints.</p>\n<p><b>Apple Glass: the next big thing</b></p>\n<p>The other key reason to own AAPL in 2022 could be the introduction of a brand-new product category. Wedbush’s Dan Ives has been&nbsp;labeling&nbsp;the new device “Apple Glass”, the company’s first attempt at penetrating the AR/VR (augmented and virtual reality) space.</p>\n<p>Mr. Ives goes further and estimates the impact of the new product on Apple stock price. According to the analyst, the product launch “could eventually add approximately $20 per share to the sum-of-the-parts value” of the shares.</p>\n<p>Wedbush is not alone in its bullish assessment.Morgan Stanley has already suggested&nbsp;that Apple unveiling a mixed reality device in 2022 would be the key catalyst for the hotly-debated metaverse to finally take off.</p>\n<p><b>The Apple Maven’s take</b></p>\n<p>Even as Apple stock reaches its all-time high of $175 apiece, I maintain my bullish stance on the name. Apple’s position as the most important player in consumer tech is at the center of the investment thesis, in my view.</p>\n<p>However, keep in mind that buying AAPL at peak price has produced one-year forward returns of “only” 25%, on average, during the iPhone era (i.e. since 2007). This number compares to a much better 46% average annual gain when the stock was bought following a 10% drawdown.</p>\n<p>From current levels, therefore, I think that investors should expect to rake in lower returns than if they were buying a dip in share price.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Reasons To Own Apple Stock in 2022: iPhone, Apple Glass</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Reasons To Own Apple Stock in 2022: iPhone, Apple Glass\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 08:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/iphone/2-reasons-to-own-apple-stock-in-2022-iphone-apple-glass><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As 2021 draws close to an end, investors seem confident that Apple stock will continue to perform strongly into the new year. Here are two reasons why they may be right.\nWall Street analysts continue ...</p>\n\n<a href=\"https://www.thestreet.com/apple/iphone/2-reasons-to-own-apple-stock-in-2022-iphone-apple-glass\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/iphone/2-reasons-to-own-apple-stock-in-2022-iphone-apple-glass","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175891189","content_text":"As 2021 draws close to an end, investors seem confident that Apple stock will continue to perform strongly into the new year. Here are two reasons why they may be right.\nWall Street analysts continue to debate whether Apple stock is a buy as we head into 2022. Recently,I presented the bear argument that, if proven right, could foretell a drop of around 18% in the stock price.\nBut investors seem to be siding with bulls at the moment, as AAPL shares continue to make fresh highs. Today, I talk about two key reasons recently presented by analysts suggesting that Apple stock could be a good bet for the new year.\nFigure 1: Apple's iPhone 13, Apple Watch and AirPods Pro.\niPhone: not all about the holiday\nThe recent headlines have highlighted the expected performance of the iPhone in the current holiday period. Bloomberg hinted at a slowdown in demand, supported by alleged order cancellations with suppliers. The data point contradicted earlier Wall Street projections for an above-estimate volume of iPhone shipments in the current shopping season.\nBut DigiTimes Taiwan has recently shifted the focus of attention to the longer term. According to the publication, Apple is looking to “[increase] iPhone shipments by 30% for the first half of next year with the larger goal of exceeding 300 million iPhone shipments in 2022.”\nIf confirmed, this would represent massive YOY improvement, especially in the first few months of the year. Keep in mind (chart below) that the Cupertino company dropped the mic on iPhone sales in the early part of 2021, setting the bar very high for growth in 2022.\nFigure 2: iPhone revenue growth since F19.\nI would warn readers, however, not to rely too much on unofficial announcements about iPhone sales. In addition to the issue of reliability of rumors, the assumption of higher shipments could be a misread on Apple ramping up iPhone production to anticipate supply chain constraints.\nApple Glass: the next big thing\nThe other key reason to own AAPL in 2022 could be the introduction of a brand-new product category. Wedbush’s Dan Ives has been labeling the new device “Apple Glass”, the company’s first attempt at penetrating the AR/VR (augmented and virtual reality) space.\nMr. Ives goes further and estimates the impact of the new product on Apple stock price. According to the analyst, the product launch “could eventually add approximately $20 per share to the sum-of-the-parts value” of the shares.\nWedbush is not alone in its bullish assessment.Morgan Stanley has already suggested that Apple unveiling a mixed reality device in 2022 would be the key catalyst for the hotly-debated metaverse to finally take off.\nThe Apple Maven’s take\nEven as Apple stock reaches its all-time high of $175 apiece, I maintain my bullish stance on the name. Apple’s position as the most important player in consumer tech is at the center of the investment thesis, in my view.\nHowever, keep in mind that buying AAPL at peak price has produced one-year forward returns of “only” 25%, on average, during the iPhone era (i.e. since 2007). This number compares to a much better 46% average annual gain when the stock was bought following a 10% drawdown.\nFrom current levels, therefore, I think that investors should expect to rake in lower returns than if they were buying a dip in share price.","news_type":1},"isVote":1,"tweetType":1,"viewCount":561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604120054,"gmtCreate":1639360588822,"gmtModify":1639360589623,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Call]&nbsp;[Call]&nbsp;[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","listText":"[Call]&nbsp;[Call]&nbsp;[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","text":"[Call] [Call] [Allin] [USD] [Call] [Like] [Bless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604120054","repostId":"1147979965","repostType":4,"repost":{"id":"1147979965","pubTimestamp":1639360066,"share":"https://www.laohu8.com/m/news/1147979965?lang=&edition=full","pubTime":"2021-12-13 09:47","market":"hk","language":"en","title":"Hong Kong: Stocks rise at the open","url":"https://stock-news.laohu8.com/highlight/detail?id=1147979965","media":"AFP","summary":"Hong Kong stocks rose at the open Monday (Dec 13), as investors took heart from US rallies.\nThe Hang","content":"<p>Hong Kong stocks rose at the open Monday (Dec 13), as investors took heart from US rallies.</p>\n<p>The Hang Seng Index was up 1.03 per cent or 246.54 points to 24,242.26.</p>\n<p>The Shanghai Composite Index inched up 0.56 per cent or 20.59 points to 3,686.94, while the Shenzhen Composite Index on China's second exchange was up 0.34 per cent or 8.59 points at 2,555.24.</p>","source":"lsy1605843958005","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong: Stocks rise at the open</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong: Stocks rise at the open\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 09:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/stocks/hong-kong-stocks-rise-at-the-open-0><strong>AFP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hong Kong stocks rose at the open Monday (Dec 13), as investors took heart from US rallies.\nThe Hang Seng Index was up 1.03 per cent or 246.54 points to 24,242.26.\nThe Shanghai Composite Index inched ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/hong-kong-stocks-rise-at-the-open-0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSTECH":"恒生科技指数","HSCEI":"国企指数","HSI":"恒生指数"},"source_url":"https://www.businesstimes.com.sg/stocks/hong-kong-stocks-rise-at-the-open-0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147979965","content_text":"Hong Kong stocks rose at the open Monday (Dec 13), as investors took heart from US rallies.\nThe Hang Seng Index was up 1.03 per cent or 246.54 points to 24,242.26.\nThe Shanghai Composite Index inched up 0.56 per cent or 20.59 points to 3,686.94, while the Shenzhen Composite Index on China's second exchange was up 0.34 per cent or 8.59 points at 2,555.24.","news_type":1},"isVote":1,"tweetType":1,"viewCount":206,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605513727,"gmtCreate":1639189565646,"gmtModify":1639190160193,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[USD]&nbsp;[Allin]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;","listText":"[USD]&nbsp;[Allin]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;","text":"[USD] [Allin] [Call] [Call] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605513727","repostId":"2190296066","repostType":4,"repost":{"id":"2190296066","pubTimestamp":1639150220,"share":"https://www.laohu8.com/m/news/2190296066?lang=&edition=full","pubTime":"2021-12-10 23:30","market":"us","language":"en","title":"The Smartest Stocks to Buy With $200 in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2190296066","media":"Motley Fool","summary":"A small investment can go a long way with this mix of growth, income, and value stocks.","content":"<p>Despite volatility rearing its head over the past couple of weeks, it's been another stellar year for the stock market. Through Dec. 6, the benchmark <b>S&amp;P 500</b> has gained 22% on a year-to-date basis. That essentially doubles up the average annual total return, including dividends, of the S&amp;P 500 since 1980 (about 11%).</p>\n<p>But just because the broader market is up big, it doesn't mean there aren't still bargains to be found. For patient investors who lean on time as their ally, there are plenty of stocks that can make them richer.</p>\n<p>Best of all, you don't need a mountain of money to build wealth on Wall Street. With most brokerages eliminating minimum deposit requirements and trading commissions, any amount of money -- even $200 -- can be the right amount to grow your portfolio.</p>\n<p>If you have $200 ready to invest, the following are some of the smartest stocks you can buy in December.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5876cf8596571681f0d3218da4f74c8c\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>CrowdStrike Holdings</h2>\n<p>One of the smartest buys investors can make is scooping up shares of premier cybersecurity stock <b>CrowdStrike Holdings</b> (NASDAQ:CRWD).</p>\n<p>Cybersecurity may not be the fastest-growing trend, but there's arguably not a safer double-digit growth opportunity through the midpoint of the decade. Since hackers and robots don't take time off just because the U.S. economy or stock market hit a rough patch, businesses are increasingly turning to third-party providers to secure their data and that of their clients.</p>\n<p>What makes CrowdStrike special is its cloud-native Falcon security platform. Falcon relies on artificial intelligence to grow smarter over time and is currently overseeing about 1 trillion events <i>per day</i>. As a cloud-based platform, Falcon is often better at recognizing and responding to threats than on-premises solutions. While CrowdStrike's solutions aren't the cheapest on a nominal basis, the long-term reward of data protection makes Falcon a more cost-effective platform for businesses.</p>\n<p>The proof is in the pudding that clients are thrilled with CrowdStrike's suite of services. The total number of subscribers has skyrocketed from 450 to almost 14,700 in less than five years, with 68% of its clients purchasing four or more cloud-module subscriptions, as of Sept. 30. The latter is up from under 10% less than five years ago. The company's customer retention rate has also hovered around 98% for two years running.</p>\n<p>CrowdStrike's stock isn't inexpensive using standard fundamental metrics. However, a valuation premium is certainly warranted with its subscription gross margin already at its long-term target this early in its expansion.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/626f702dc64e03a6186f9231d5b698b4\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>AT&amp;T</h2>\n<p>Keep in mind that it's not just growth stocks that are begging to be bought. Value and income plays like telecom stock <b>AT&amp;T</b> (NYSE:T) represent a smart way to put $200 to work right now.</p>\n<p>To state the obvious, AT&amp;T's high-growth heyday is long gone. But just because the company has matured, it doesn't mean there aren't organic growth opportunities on its doorstep.</p>\n<p>For instance, AT&amp;T should benefit nicely from the ongoing rollout of 5G wireless infrastructure. Although upgrading its infrastructure won't be cheap, the investment will pay off handsomely. That's because it's been a decade since wireless download speeds were meaningfully improved. With 5G becoming widely available, consumers and businesses are liable to undertake a multiyear device upgrade cycle to take advantage of a faster network. Since the bulk of AT&amp;T's wireless margins derive from data consumption, 5G should provide a healthy shot of organic growth through at least 2025.</p>\n<p>AT&amp;T is also in the process of spinning off its content arm, WarnerMedia, and combining it with <b>Discovery</b>&nbsp;to create a new media powerhouse. The new company should have over 85 million streaming subscribers, a more diverse content library, and it'll be able to cut its operating costs by over $3 billion a year.</p>\n<p>At an estimated 7 times forecasted earnings per share this year, and a high-yield dividend to boot, AT&amp;T is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the smartest value and income plays to buy now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5aacd35062c7935f82d018ba2d593ab6\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Exelixis</h2>\n<p>Another genius purchase investors can make in December with $200 is biotech stock <b>Exelixis</b> (NASDAQ:EXEL).</p>\n<p>Exelixis has had a bit of a rough year, with its shares down close to 20%. The cancer-focused drug developer disappointed Wall Street in late June when it unveiled interim analysis data from the late-stage Cosmic-312 study in patients with previously untreated liver cancer. The company's lead drug, Cabometyx, was paired with atezolizumab (better known by its brand name, Tecentriq) in this study. While progression-free survival data hit the mark, the company noted it was unlikely that overall survival data would show a statistically significant improvement versus Nexavar.</p>\n<p>Though this was undoubtedly disappointing, as first-line hepatocellular carcinoma (HCC) is an indication that could use more-effective treatments, the downside Exelixis' shares have seen since this data release looks to be an overreaction.</p>\n<p>Even assuming the Food and Drug Administration doesn't grant this combo treatment approval in first-line HCC -- the company plans to file a supplemental new drug application in Q1 2022 -- Cabometyx is in line for well over $1 billion in annual revenue from first- and second-line kidney cancer indications and more advanced cases of HCC.</p>\n<p>Furthermore, Cabometyx is being examined in close to six dozen clinical trials. Some failures are expected. But if even a handful of these studies result in label expansion opportunities, Cabometyx could surpass $2 billion in annual sales.</p>\n<p>With Exelixis sitting on a whopping $1.8 billion in cash, cash equivalents, and restricted cash equivalents and investments (this is about 35% of its market cap), and the company's price-earnings-to-growth ratio well below 1, it has all the hallmarks of a screaming buy.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b13f98298635a74f4491a99bf47eeded\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a></h2>\n<p>A final smart stock investors can buy with $200 in December is pharmacy chain <b>Walgreens Boots Alliance</b> (NASDAQ:WBA). Similar to AT&amp;T, this is another value/income play that's not getting the love it deserves.</p>\n<p>Normally, healthcare stocks aren't adversely affected by economic downturns. Since we can't control when we get sick or what ailment(s) we develop, there's always demand for drugs, devices, and healthcare services. But during the pandemic, Walgreens wasn't as lucky. Reduced foot traffic hurt demand for front-end sales and clinic revenue.</p>\n<p>That's the bad news. The good news is Walgreens is incredibly inexpensive following the worst of the pandemic, and it's already well into a multipoint turnaround plan designed to increase margins and boost its organic growth rate.</p>\n<p>Initially, management anticipated reducing annual operating expenses by $2 billion as of the end of fiscal 2022. But cost-cutting activity has been far better than expected. Walgreens achieved more than $2 billion in annual cost reductions, and it did so by the end of fiscal 2021.</p>\n<p>However, it's not cost-cutting that should have investors excited. Rather, it's the company's investments. For example, Walgreens has spared no expense when it comes to its investments in digitization. Placing greater emphasis on direct-to-consumer sales should result in sustainable double-digit online revenue growth.</p>\n<p>Walgreens has also partnered with VillageMD to open more than 600 full-service clinics in over 30 U.S. markets by 2025. These co-located clinics will be physician-staffed and should play a key role in funneling local residents to the company's higher-margin pharmacy.</p>\n<p>At less than 10 times Wall Street's forecasted earnings per share for fiscal 2022, Walgreens Boots Alliance is a steal.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Smartest Stocks to Buy With $200 in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Smartest Stocks to Buy With $200 in December\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/10/the-smartest-stocks-to-buy-with-200-in-december/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite volatility rearing its head over the past couple of weeks, it's been another stellar year for the stock market. Through Dec. 6, the benchmark S&P 500 has gained 22% on a year-to-date basis. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/10/the-smartest-stocks-to-buy-with-200-in-december/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRWD":"CrowdStrike Holdings, Inc.","BK4097":"系统软件","T":"美国电话电报","BK4534":"瑞士信贷持仓","EXEL":"伊克力西斯","BK4006":"钢铁","BK4139":"生物科技","BK4128":"药品零售","BK4560":"网络安全概念","BK4550":"红杉资本持仓","BK4528":"SaaS概念","BK4115":"综合电信业务","HCC":"Warrior Met Coal LLC","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","WBA":"沃尔格林联合博姿","BK4507":"流媒体概念","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/10/the-smartest-stocks-to-buy-with-200-in-december/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190296066","content_text":"Despite volatility rearing its head over the past couple of weeks, it's been another stellar year for the stock market. Through Dec. 6, the benchmark S&P 500 has gained 22% on a year-to-date basis. That essentially doubles up the average annual total return, including dividends, of the S&P 500 since 1980 (about 11%).\nBut just because the broader market is up big, it doesn't mean there aren't still bargains to be found. For patient investors who lean on time as their ally, there are plenty of stocks that can make them richer.\nBest of all, you don't need a mountain of money to build wealth on Wall Street. With most brokerages eliminating minimum deposit requirements and trading commissions, any amount of money -- even $200 -- can be the right amount to grow your portfolio.\nIf you have $200 ready to invest, the following are some of the smartest stocks you can buy in December.\nImage source: Getty Images.\nCrowdStrike Holdings\nOne of the smartest buys investors can make is scooping up shares of premier cybersecurity stock CrowdStrike Holdings (NASDAQ:CRWD).\nCybersecurity may not be the fastest-growing trend, but there's arguably not a safer double-digit growth opportunity through the midpoint of the decade. Since hackers and robots don't take time off just because the U.S. economy or stock market hit a rough patch, businesses are increasingly turning to third-party providers to secure their data and that of their clients.\nWhat makes CrowdStrike special is its cloud-native Falcon security platform. Falcon relies on artificial intelligence to grow smarter over time and is currently overseeing about 1 trillion events per day. As a cloud-based platform, Falcon is often better at recognizing and responding to threats than on-premises solutions. While CrowdStrike's solutions aren't the cheapest on a nominal basis, the long-term reward of data protection makes Falcon a more cost-effective platform for businesses.\nThe proof is in the pudding that clients are thrilled with CrowdStrike's suite of services. The total number of subscribers has skyrocketed from 450 to almost 14,700 in less than five years, with 68% of its clients purchasing four or more cloud-module subscriptions, as of Sept. 30. The latter is up from under 10% less than five years ago. The company's customer retention rate has also hovered around 98% for two years running.\nCrowdStrike's stock isn't inexpensive using standard fundamental metrics. However, a valuation premium is certainly warranted with its subscription gross margin already at its long-term target this early in its expansion.\nImage source: Getty Images.\nAT&T\nKeep in mind that it's not just growth stocks that are begging to be bought. Value and income plays like telecom stock AT&T (NYSE:T) represent a smart way to put $200 to work right now.\nTo state the obvious, AT&T's high-growth heyday is long gone. But just because the company has matured, it doesn't mean there aren't organic growth opportunities on its doorstep.\nFor instance, AT&T should benefit nicely from the ongoing rollout of 5G wireless infrastructure. Although upgrading its infrastructure won't be cheap, the investment will pay off handsomely. That's because it's been a decade since wireless download speeds were meaningfully improved. With 5G becoming widely available, consumers and businesses are liable to undertake a multiyear device upgrade cycle to take advantage of a faster network. Since the bulk of AT&T's wireless margins derive from data consumption, 5G should provide a healthy shot of organic growth through at least 2025.\nAT&T is also in the process of spinning off its content arm, WarnerMedia, and combining it with Discovery to create a new media powerhouse. The new company should have over 85 million streaming subscribers, a more diverse content library, and it'll be able to cut its operating costs by over $3 billion a year.\nAt an estimated 7 times forecasted earnings per share this year, and a high-yield dividend to boot, AT&T is one of the smartest value and income plays to buy now.\nImage source: Getty Images.\nExelixis\nAnother genius purchase investors can make in December with $200 is biotech stock Exelixis (NASDAQ:EXEL).\nExelixis has had a bit of a rough year, with its shares down close to 20%. The cancer-focused drug developer disappointed Wall Street in late June when it unveiled interim analysis data from the late-stage Cosmic-312 study in patients with previously untreated liver cancer. The company's lead drug, Cabometyx, was paired with atezolizumab (better known by its brand name, Tecentriq) in this study. While progression-free survival data hit the mark, the company noted it was unlikely that overall survival data would show a statistically significant improvement versus Nexavar.\nThough this was undoubtedly disappointing, as first-line hepatocellular carcinoma (HCC) is an indication that could use more-effective treatments, the downside Exelixis' shares have seen since this data release looks to be an overreaction.\nEven assuming the Food and Drug Administration doesn't grant this combo treatment approval in first-line HCC -- the company plans to file a supplemental new drug application in Q1 2022 -- Cabometyx is in line for well over $1 billion in annual revenue from first- and second-line kidney cancer indications and more advanced cases of HCC.\nFurthermore, Cabometyx is being examined in close to six dozen clinical trials. Some failures are expected. But if even a handful of these studies result in label expansion opportunities, Cabometyx could surpass $2 billion in annual sales.\nWith Exelixis sitting on a whopping $1.8 billion in cash, cash equivalents, and restricted cash equivalents and investments (this is about 35% of its market cap), and the company's price-earnings-to-growth ratio well below 1, it has all the hallmarks of a screaming buy.\nImage source: Getty Images.\nWalgreens Boots Alliance\nA final smart stock investors can buy with $200 in December is pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA). Similar to AT&T, this is another value/income play that's not getting the love it deserves.\nNormally, healthcare stocks aren't adversely affected by economic downturns. Since we can't control when we get sick or what ailment(s) we develop, there's always demand for drugs, devices, and healthcare services. But during the pandemic, Walgreens wasn't as lucky. Reduced foot traffic hurt demand for front-end sales and clinic revenue.\nThat's the bad news. The good news is Walgreens is incredibly inexpensive following the worst of the pandemic, and it's already well into a multipoint turnaround plan designed to increase margins and boost its organic growth rate.\nInitially, management anticipated reducing annual operating expenses by $2 billion as of the end of fiscal 2022. But cost-cutting activity has been far better than expected. Walgreens achieved more than $2 billion in annual cost reductions, and it did so by the end of fiscal 2021.\nHowever, it's not cost-cutting that should have investors excited. Rather, it's the company's investments. For example, Walgreens has spared no expense when it comes to its investments in digitization. Placing greater emphasis on direct-to-consumer sales should result in sustainable double-digit online revenue growth.\nWalgreens has also partnered with VillageMD to open more than 600 full-service clinics in over 30 U.S. markets by 2025. These co-located clinics will be physician-staffed and should play a key role in funneling local residents to the company's higher-margin pharmacy.\nAt less than 10 times Wall Street's forecasted earnings per share for fiscal 2022, Walgreens Boots Alliance is a steal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601513657,"gmtCreate":1638542568606,"gmtModify":1638542569002,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Bless]&nbsp;[Like]&nbsp;[Like]&nbsp;","listText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Bless]&nbsp;[Like]&nbsp;[Like]&nbsp;","text":"[Allin] [USD] [Call] [Bless] [Like] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601513657","repostId":"1131080801","repostType":2,"repost":{"id":"1131080801","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638542459,"share":"https://www.laohu8.com/m/news/1131080801?lang=&edition=full","pubTime":"2021-12-03 22:40","market":"us","language":"en","title":"EV stocks dropped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1131080801","media":"Tiger Newspress","summary":"EV stocks dropped in morning trading.Tesla,Rivian,Nio,Xpeng Motors,Li Auto,Lucid,Fisker,Arrival,Niko","content":"<p>EV stocks dropped in morning trading.Tesla,Rivian,Nio,Xpeng Motors,Li Auto,Lucid,Fisker,Arrival,Nikola&nbsp;and&nbsp;Canoo&nbsp;fell between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/cbf8e30e272a117eda3223586e403ba3\" tg-width=\"408\" tg-height=\"601\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks dropped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks dropped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EV stocks dropped in morning trading.Tesla,Rivian,Nio,Xpeng Motors,Li Auto,Lucid,Fisker,Arrival,Nikola&nbsp;and&nbsp;Canoo&nbsp;fell between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/cbf8e30e272a117eda3223586e403ba3\" tg-width=\"408\" tg-height=\"601\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc","LI":"理想汽车","TSLA":"特斯拉","NIO":"蔚来","GOEV":"Canoo Inc.","RIVN":"Rivian Automotive, Inc.","NKLA":"Nikola Corporation","FSR":"菲斯克","XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131080801","content_text":"EV stocks dropped in morning trading.Tesla,Rivian,Nio,Xpeng Motors,Li Auto,Lucid,Fisker,Arrival,Nikola and Canoo fell between 1% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603540563,"gmtCreate":1638432436856,"gmtModify":1638432456355,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[梭哈]&nbsp;[美金]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[强]&nbsp;","listText":"[梭哈]&nbsp;[美金]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[强]&nbsp;","text":"[梭哈] [美金] [看涨] [看涨] [看涨] [强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603540563","repostId":"1101503578","repostType":4,"repost":{"id":"1101503578","pubTimestamp":1638432046,"share":"https://www.laohu8.com/m/news/1101503578?lang=&edition=full","pubTime":"2021-12-02 16:00","market":"us","language":"en","title":"Wait to Buy CrowdStrike at Support as a Quality Cybersecurity Play","url":"https://stock-news.laohu8.com/highlight/detail?id=1101503578","media":"InvestorPlace","summary":"Down from its highs, CRWD stock is a perfect opportunity as cyberattacks are on the rise","content":"<p>It feels bad to sell too early if you’re in a winning trade. That was my experience with&nbsp;<b>CrowdStrike</b>&nbsp;(NASDAQ:<b><u>CRWD</u></b>) as I unloaded shares at $140. CRWD stock then proceeded to trend much higher, exceeding even my most lofty expectations.</p>\n<p>There has been a drastic shift in opportunity for the company as the pandemic’s early days subside. This is why they say a large portion of the success in investing has to do with psychology.</p>\n<p>I want to take a fresh look at CRWD stock today from a new perspective. It has had difficulty breaking through its high of $287. The stock would always quickly retrace after hitting this level, indicating weakness in buying momentum. The stock finally had a short breakdown late in November.</p>\n<p>While I don’t think this is yet the optimal price for CRWD stock, investors should keep this one on their watch list and wait for a bottom.</p>\n<p><b>Cyberattack Threat is Increasing</b></p>\n<p>The threat of Cyberattacks has been increasing exponentially these past few years. This is especially true now, as so many aspect of our lives have moved entirely digital in response to the Covid-19 pandemic. Many people are now working from home rather than the office, connecting via the web and engaging in online entertainment like movies or games.</p>\n<p>This year, we have seen a number of high-profile cyberattacks on companies such as&nbsp;<b>Solar Winds</b>(NYSE:<b><u>SWI</u></b>) and&nbsp;<b>Colonial Pipeline</b>. The number of breaches in 2021 exceeded the number in 2020.</p>\n<p>It could be a record-breaking year for security breaches. The frequency and scale of these breaches demonstrate the country’s vulnerability from cyberattacks.</p>\n<p>Eva Velasquez, President and CEO of the&nbsp;<b>Identity Theft Resource Center</b>, said: “It’s also interesting to note that the 1,111 data breaches that the amount and quality of data being exfiltrated by hackers. from cyber-attacks so far, this year exceeds the total number of data compromises from all causes in 2020.”</p>\n<p>Cyberattacks can be extremely costly. According to&nbsp;<b>Cybersecurity Ventures</b>, the costs of ransomware alone could potentially reach $265 billion in the next 10 years. These factors have increased the need for individuals and corporations to start protecting their digital assets.</p>\n<p><b>CRWD Stock Has Plenty of Potential</b></p>\n<p>CrowdStrike is one of the preeminent cybersecurity companies on the market today. The company’s&nbsp;Falcon platform&nbsp;was built from the ground up to protect against threats in the cloud era. The Falcon is a multi-tenant and cloud-native solution that could protect enterprises no matter where they work. Whether a company uses on-premise or cloud technology, CrowdStrike is able to defend its clients against cyberattacks.</p>\n<p>Given the immense potential of the company, CRWD stock tends to trade at a large premium. The stock is trading at a trailing 12-month price-to-sales (P/S) ratio of 44x. Using forward earnings estimates, the stock is trading at a price-to-earnings (P/E) ratio of 277x. Neither of these valuation metrics indicate a cheap company, but you need to pay for quality in this frothy environment.</p>\n<p>However, the large selloff could create some opportunity, and CRWD stock is a quality investment that a potential buyer should hold for a long time. The stock is currently 20% below its most recent high. There is a chance, though, that this selloff could continue.</p>\n<p>If CRWD stock enters a down-trending channel, I wouldn’t be surprised to see it trade close to $180. This would be a 37% premium from even the most pessimistic analyst price&nbsp;target of $247. I continue to like CRWD stock and am waiting for an ideal point of entry.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wait to Buy CrowdStrike at Support as a Quality Cybersecurity Play</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWait to Buy CrowdStrike at Support as a Quality Cybersecurity Play\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 16:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/wait-to-buy-crwd-stock-at-support-as-a-quality-cybersecurity-play/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It feels bad to sell too early if you’re in a winning trade. That was my experience with CrowdStrike (NASDAQ:CRWD) as I unloaded shares at $140. CRWD stock then proceeded to trend much higher, ...</p>\n\n<a href=\"https://investorplace.com/2021/12/wait-to-buy-crwd-stock-at-support-as-a-quality-cybersecurity-play/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRWD":"CrowdStrike Holdings, Inc."},"source_url":"https://investorplace.com/2021/12/wait-to-buy-crwd-stock-at-support-as-a-quality-cybersecurity-play/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101503578","content_text":"It feels bad to sell too early if you’re in a winning trade. That was my experience with CrowdStrike (NASDAQ:CRWD) as I unloaded shares at $140. CRWD stock then proceeded to trend much higher, exceeding even my most lofty expectations.\nThere has been a drastic shift in opportunity for the company as the pandemic’s early days subside. This is why they say a large portion of the success in investing has to do with psychology.\nI want to take a fresh look at CRWD stock today from a new perspective. It has had difficulty breaking through its high of $287. The stock would always quickly retrace after hitting this level, indicating weakness in buying momentum. The stock finally had a short breakdown late in November.\nWhile I don’t think this is yet the optimal price for CRWD stock, investors should keep this one on their watch list and wait for a bottom.\nCyberattack Threat is Increasing\nThe threat of Cyberattacks has been increasing exponentially these past few years. This is especially true now, as so many aspect of our lives have moved entirely digital in response to the Covid-19 pandemic. Many people are now working from home rather than the office, connecting via the web and engaging in online entertainment like movies or games.\nThis year, we have seen a number of high-profile cyberattacks on companies such as Solar Winds(NYSE:SWI) and Colonial Pipeline. The number of breaches in 2021 exceeded the number in 2020.\nIt could be a record-breaking year for security breaches. The frequency and scale of these breaches demonstrate the country’s vulnerability from cyberattacks.\nEva Velasquez, President and CEO of the Identity Theft Resource Center, said: “It’s also interesting to note that the 1,111 data breaches that the amount and quality of data being exfiltrated by hackers. from cyber-attacks so far, this year exceeds the total number of data compromises from all causes in 2020.”\nCyberattacks can be extremely costly. According to Cybersecurity Ventures, the costs of ransomware alone could potentially reach $265 billion in the next 10 years. These factors have increased the need for individuals and corporations to start protecting their digital assets.\nCRWD Stock Has Plenty of Potential\nCrowdStrike is one of the preeminent cybersecurity companies on the market today. The company’s Falcon platform was built from the ground up to protect against threats in the cloud era. The Falcon is a multi-tenant and cloud-native solution that could protect enterprises no matter where they work. Whether a company uses on-premise or cloud technology, CrowdStrike is able to defend its clients against cyberattacks.\nGiven the immense potential of the company, CRWD stock tends to trade at a large premium. The stock is trading at a trailing 12-month price-to-sales (P/S) ratio of 44x. Using forward earnings estimates, the stock is trading at a price-to-earnings (P/E) ratio of 277x. Neither of these valuation metrics indicate a cheap company, but you need to pay for quality in this frothy environment.\nHowever, the large selloff could create some opportunity, and CRWD stock is a quality investment that a potential buyer should hold for a long time. The stock is currently 20% below its most recent high. There is a chance, though, that this selloff could continue.\nIf CRWD stock enters a down-trending channel, I wouldn’t be surprised to see it trade close to $180. This would be a 37% premium from even the most pessimistic analyst price target of $247. I continue to like CRWD stock and am waiting for an ideal point of entry.","news_type":1},"isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609048885,"gmtCreate":1638227799785,"gmtModify":1638227801100,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[看涨]&nbsp;[强]&nbsp;","listText":"[看涨]&nbsp;[强]&nbsp;","text":"[看涨] [强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609048885","repostId":"1140086726","repostType":4,"repost":{"id":"1140086726","pubTimestamp":1638199972,"share":"https://www.laohu8.com/m/news/1140086726?lang=&edition=full","pubTime":"2021-11-29 23:32","market":"us","language":"en","title":"Zoom Stock: Growth A Concern, But Experts See 42% Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=1140086726","media":"TheStreet","summary":"Despite reporting Q3 top- and bottom-line beats, Zoom guided low for 2022 and shares dropped 17% aft","content":"<p>Despite reporting Q3 top- and bottom-line beats, Zoom guided low for 2022 and shares dropped 17% after earnings. Yet, experts see upside ahead for $ZM stock.</p>\n<p>Zoom Video&nbsp;reported Q3 results on November 22, after the closing bell. Despite an EPS and revenue beat, poor guidance disappointed, and the stock sank more than 17% since earnings day.</p>\n<p>After Zoom’s earnings bummer, several Wall Street experts updated their price targets lower. Still, following the recent selloff, consensus now suggests that ZM has upside potential of over 40% ahead, despite growth concerns in a post-pandemic environment.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62bf3114b685604e5e71c6b7c3e4edcd\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Zoom headquarters on Almaden Boulevard in San Jose, California. Photographed on June 21, 2020.</span></p>\n<p><b>Q3 earnings beat, but growth is a concern</b></p>\n<p>Zoom Video&nbsp;reported&nbsp;EPS and revenue beats of 2 cents and $31 million, respectively. The results were far from disastrous, but they mattered little for investor sentiment. Poor guidance is what disappointed most, since Zoom forecasted lower growth than witnessed in the past two years.</p>\n<p>The company&nbsp;expects&nbsp;Q4 revenues to climb only 19% YOY, which should be about in line with the $1.05 billion in revenues reported in Q3. It was not a surprise that Zoom would struggle to maintain the growth trajectory, as the stay-at-home trends of the pandemic year are no longer in place.</p>\n<p>During Zoom’s earnings call, CFO Kelly Steckelberg&nbsp;spoke&nbsp;of the company’s challenges ahead:</p>\n<blockquote>\n <i>\"We're still having these online customers which are the most volatile [and] many of them are still on monthly contracts. And as they are adjusting to the environment and figuring out how the future of work is going to be for them individually, we expect that to be the challenging headwind.\"</i>\n</blockquote>\n<p><b>Wall Street’s thoughts after Q3 earnings</b></p>\n<p>Despite the company having announced challenges ahead, Wall Street analysts still believe that ZM could be undervalued and that it has substantial gain potential over the next year.</p>\n<p>Based&nbsp;on 11 Wall Street analysts that offered twelve-month price targets on Zoom stock after Q3 earnings, 6 of them have a buy recommendation and 5 are neutral. Still, even though consensus rating is not a buy, 42% upside potential from current levels is&nbsp;projected, on average.</p>\n<p>Morgan Stanley’s Meta Marshall says that Zoom Video&nbsp;outperformed&nbsp;low expectations in Q3 as execution has been consistent with the strategy. The analyst reinforced the buy recommendation and forecasts a $365 price, representing 76% upside potential. The bullish target takes into account massive growth of 94% in revenues from customers contributing more than $100,000; and above-average expansion of the larger enterprise vertical (i.e. 10 employees or more).</p>\n<p>Piper Sandler’s James Fish&nbsp;lowered&nbsp;the firm's price target on ZM stock to $299 from $369, despite maintaining his buy recommendation and still seeing 44% upside potential ahead. He believes that Zoom’s Q3 results were \"net-encouraging\", and that the churn rate showcased stability. The price target cut was justified by “multiple compression and a trough likely to occur next year”.</p>\n<p>Skeptical, with a neutral rating on ZM and a $235 price target, Evercore ISI’s Peter Levine&nbsp;forecasts&nbsp;margins coming down in January 2023, as the company ramps up investments in both research and development, and sales and marketing. Despite seeing a more reasonable valuation for Zoom, he also sees several challenges ahead for the stock.</p>\n<p>Also skeptical, Deutsche Bank analyst Matthew Nikam&nbsp;lowered&nbsp;the firm's price target on Zoom Video to $280 from $350, maintaining a neutral rating on the shares following Q3 results. The analyst said that it is \"tougher to like a stock with more sharply decelerating growth and incremental pressure on profitability”. However, he sees positive strategic initiatives in key growth areas.</p>\n<p>Lastly, Mizuho analyst Siti Panigrahi also&nbsp;lowered&nbsp;the firm's price target on Zoom to $300 from $350, while he still maintained a buy recommendation on the stock and a 45% gain forecast. Zoom’s Q3 earnings above consensus “cleared a lowered bar”, aided by better-than-expected online churn ratio and revenue growth. The analyst also said that despite Zoom’s post pandemic growth being under pressure, Zoom Phone, Zoom Rooms and Video Engagement Center will remain crucial for hybrid workers going forward.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zoom Stock: Growth A Concern, But Experts See 42% Upside</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZoom Stock: Growth A Concern, But Experts See 42% Upside\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 23:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/reddit-trends/zoom-stock-growth-a-concern-but-experts-see-42-upside><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite reporting Q3 top- and bottom-line beats, Zoom guided low for 2022 and shares dropped 17% after earnings. Yet, experts see upside ahead for $ZM stock.\nZoom Video reported Q3 results on November...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/reddit-trends/zoom-stock-growth-a-concern-but-experts-see-42-upside\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom"},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/zoom-stock-growth-a-concern-but-experts-see-42-upside","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140086726","content_text":"Despite reporting Q3 top- and bottom-line beats, Zoom guided low for 2022 and shares dropped 17% after earnings. Yet, experts see upside ahead for $ZM stock.\nZoom Video reported Q3 results on November 22, after the closing bell. Despite an EPS and revenue beat, poor guidance disappointed, and the stock sank more than 17% since earnings day.\nAfter Zoom’s earnings bummer, several Wall Street experts updated their price targets lower. Still, following the recent selloff, consensus now suggests that ZM has upside potential of over 40% ahead, despite growth concerns in a post-pandemic environment.\nFigure 1: Zoom headquarters on Almaden Boulevard in San Jose, California. Photographed on June 21, 2020.\nQ3 earnings beat, but growth is a concern\nZoom Video reported EPS and revenue beats of 2 cents and $31 million, respectively. The results were far from disastrous, but they mattered little for investor sentiment. Poor guidance is what disappointed most, since Zoom forecasted lower growth than witnessed in the past two years.\nThe company expects Q4 revenues to climb only 19% YOY, which should be about in line with the $1.05 billion in revenues reported in Q3. It was not a surprise that Zoom would struggle to maintain the growth trajectory, as the stay-at-home trends of the pandemic year are no longer in place.\nDuring Zoom’s earnings call, CFO Kelly Steckelberg spoke of the company’s challenges ahead:\n\n\"We're still having these online customers which are the most volatile [and] many of them are still on monthly contracts. And as they are adjusting to the environment and figuring out how the future of work is going to be for them individually, we expect that to be the challenging headwind.\"\n\nWall Street’s thoughts after Q3 earnings\nDespite the company having announced challenges ahead, Wall Street analysts still believe that ZM could be undervalued and that it has substantial gain potential over the next year.\nBased on 11 Wall Street analysts that offered twelve-month price targets on Zoom stock after Q3 earnings, 6 of them have a buy recommendation and 5 are neutral. Still, even though consensus rating is not a buy, 42% upside potential from current levels is projected, on average.\nMorgan Stanley’s Meta Marshall says that Zoom Video outperformed low expectations in Q3 as execution has been consistent with the strategy. The analyst reinforced the buy recommendation and forecasts a $365 price, representing 76% upside potential. The bullish target takes into account massive growth of 94% in revenues from customers contributing more than $100,000; and above-average expansion of the larger enterprise vertical (i.e. 10 employees or more).\nPiper Sandler’s James Fish lowered the firm's price target on ZM stock to $299 from $369, despite maintaining his buy recommendation and still seeing 44% upside potential ahead. He believes that Zoom’s Q3 results were \"net-encouraging\", and that the churn rate showcased stability. The price target cut was justified by “multiple compression and a trough likely to occur next year”.\nSkeptical, with a neutral rating on ZM and a $235 price target, Evercore ISI’s Peter Levine forecasts margins coming down in January 2023, as the company ramps up investments in both research and development, and sales and marketing. Despite seeing a more reasonable valuation for Zoom, he also sees several challenges ahead for the stock.\nAlso skeptical, Deutsche Bank analyst Matthew Nikam lowered the firm's price target on Zoom Video to $280 from $350, maintaining a neutral rating on the shares following Q3 results. The analyst said that it is \"tougher to like a stock with more sharply decelerating growth and incremental pressure on profitability”. However, he sees positive strategic initiatives in key growth areas.\nLastly, Mizuho analyst Siti Panigrahi also lowered the firm's price target on Zoom to $300 from $350, while he still maintained a buy recommendation on the stock and a 45% gain forecast. Zoom’s Q3 earnings above consensus “cleared a lowered bar”, aided by better-than-expected online churn ratio and revenue growth. The analyst also said that despite Zoom’s post pandemic growth being under pressure, Zoom Phone, Zoom Rooms and Video Engagement Center will remain crucial for hybrid workers going forward.","news_type":1},"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609041754,"gmtCreate":1638227759047,"gmtModify":1638227760275,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[吃瓜]&nbsp;","listText":"[吃瓜]&nbsp;","text":"[吃瓜]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609041754","repostId":"1101678462","repostType":4,"repost":{"id":"1101678462","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638200959,"share":"https://www.laohu8.com/m/news/1101678462?lang=&edition=full","pubTime":"2021-11-29 23:49","market":"us","language":"en","title":"Twitter CTO Parag Agrawal will replace Jack Dorsey as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1101678462","media":"Tiger Newspress","summary":"Twitter CEO Jack Dorsey is stepping down as chief of the social media company, effective immediately","content":"<p>Twitter&nbsp;CEO Jack Dorsey is stepping down as chief of the social media company, effective immediately. Parag Agrawal, the company’s chief technology officer, will take over the helm, the&nbsp;company said&nbsp;Monday.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/add9639ee2571b77d87d6436481c75f0\" tg-width=\"630\" tg-height=\"354\" width=\"100%\" height=\"auto\"><span>Twitter CEO Jack Dorsey addresses students during a town hall at the Indian Institute of Technology (IIT) in New Delhi, India, November 12, 2018.</span></p>\n<p>Dorsey, 45, was serving as both the CEO of Twitter and&nbsp;Square, his digital payments company. Dorsey will remain a member of the Board until his term expires at the 2022 meeting of stockholders, the company said.</p>\n<p>“I’ve decided to leave Twitter because I believe the company is ready to move on from its founders,” Dorsey said in a statement.</p>\n<p>Agrawal will have to meet Twitter’s&nbsp;aggressive internal goals. The company said earlier this year&nbsp;it aims to have 315 million monetizable daily active users by the end of 2023 and to at least double its annual revenue in that year.</p>\n<p>Dorsey, who co-founded the social media giant in 2006, served as CEO until 2008 before being&nbsp;pushed out of the role. He returned to Twitter as boss in 2015 after former CEO Dick Costolo stepped down.</p>\n<p>Shares have jumped 85% since Dorsey took over as CEO Oct 5. 2015. Meantime, Square shares have surged&nbsp;1,566% since its Nov. 19, 2015 initial public offering.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Twitter CTO Parag Agrawal will replace Jack Dorsey as CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwitter CTO Parag Agrawal will replace Jack Dorsey as CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-29 23:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Twitter&nbsp;CEO Jack Dorsey is stepping down as chief of the social media company, effective immediately. Parag Agrawal, the company’s chief technology officer, will take over the helm, the&nbsp;company said&nbsp;Monday.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/add9639ee2571b77d87d6436481c75f0\" tg-width=\"630\" tg-height=\"354\" width=\"100%\" height=\"auto\"><span>Twitter CEO Jack Dorsey addresses students during a town hall at the Indian Institute of Technology (IIT) in New Delhi, India, November 12, 2018.</span></p>\n<p>Dorsey, 45, was serving as both the CEO of Twitter and&nbsp;Square, his digital payments company. Dorsey will remain a member of the Board until his term expires at the 2022 meeting of stockholders, the company said.</p>\n<p>“I’ve decided to leave Twitter because I believe the company is ready to move on from its founders,” Dorsey said in a statement.</p>\n<p>Agrawal will have to meet Twitter’s&nbsp;aggressive internal goals. The company said earlier this year&nbsp;it aims to have 315 million monetizable daily active users by the end of 2023 and to at least double its annual revenue in that year.</p>\n<p>Dorsey, who co-founded the social media giant in 2006, served as CEO until 2008 before being&nbsp;pushed out of the role. He returned to Twitter as boss in 2015 after former CEO Dick Costolo stepped down.</p>\n<p>Shares have jumped 85% since Dorsey took over as CEO Oct 5. 2015. Meantime, Square shares have surged&nbsp;1,566% since its Nov. 19, 2015 initial public offering.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWTR":"Twitter"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101678462","content_text":"Twitter CEO Jack Dorsey is stepping down as chief of the social media company, effective immediately. Parag Agrawal, the company’s chief technology officer, will take over the helm, the company said Monday.\nTwitter CEO Jack Dorsey addresses students during a town hall at the Indian Institute of Technology (IIT) in New Delhi, India, November 12, 2018.\nDorsey, 45, was serving as both the CEO of Twitter and Square, his digital payments company. Dorsey will remain a member of the Board until his term expires at the 2022 meeting of stockholders, the company said.\n“I’ve decided to leave Twitter because I believe the company is ready to move on from its founders,” Dorsey said in a statement.\nAgrawal will have to meet Twitter’s aggressive internal goals. The company said earlier this year it aims to have 315 million monetizable daily active users by the end of 2023 and to at least double its annual revenue in that year.\nDorsey, who co-founded the social media giant in 2006, served as CEO until 2008 before being pushed out of the role. He returned to Twitter as boss in 2015 after former CEO Dick Costolo stepped down.\nShares have jumped 85% since Dorsey took over as CEO Oct 5. 2015. Meantime, Square shares have surged 1,566% since its Nov. 19, 2015 initial public offering.","news_type":1},"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600786960,"gmtCreate":1638197990281,"gmtModify":1638197995468,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[冷漠]&nbsp;[可怜]&nbsp;[叹气]&nbsp;[疑问]&nbsp;[心碎]&nbsp;","listText":"[冷漠]&nbsp;[可怜]&nbsp;[叹气]&nbsp;[疑问]&nbsp;[心碎]&nbsp;","text":"[冷漠] [可怜] [叹气] [疑问] [心碎]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600786960","repostId":"1137393357","repostType":2,"repost":{"id":"1137393357","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638197348,"share":"https://www.laohu8.com/m/news/1137393357?lang=&edition=full","pubTime":"2021-11-29 22:49","market":"us","language":"en","title":"Merck stock dipped more than 4% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137393357","media":"Tiger Newspress","summary":"Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi ","content":"<p>Merck stock dipped more than 4% in morning trading&nbsp;as&nbsp;it&nbsp;was downgraded to neutral from buy by Citi Research.</p>\n<p><img src=\"https://static.tigerbbs.com/921cc70c00deb0f565b98bc2a7218479\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Disappointing results for some major drugs has limited the upside for&nbsp;Merck’s stock, according to Citi.</p>\n<p>Analyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.</p>\n<p>“Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.</p>\n<p>Citi cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck stock dipped more than 4% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck stock dipped more than 4% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-29 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Merck stock dipped more than 4% in morning trading&nbsp;as&nbsp;it&nbsp;was downgraded to neutral from buy by Citi Research.</p>\n<p><img src=\"https://static.tigerbbs.com/921cc70c00deb0f565b98bc2a7218479\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Disappointing results for some major drugs has limited the upside for&nbsp;Merck’s stock, according to Citi.</p>\n<p>Analyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.</p>\n<p>“Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.</p>\n<p>Citi cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137393357","content_text":"Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi Research.\n\nDisappointing results for some major drugs has limited the upside for Merck’s stock, according to Citi.\nAnalyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.\n“Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.\nCiti cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877603944,"gmtCreate":1637919454809,"gmtModify":1637919455163,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[捂脸]&nbsp;[叹气]&nbsp;","listText":"[捂脸]&nbsp;[叹气]&nbsp;","text":"[捂脸] [叹气]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877603944","repostId":"1192622087","repostType":2,"repost":{"id":"1192622087","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637918307,"share":"https://www.laohu8.com/m/news/1192622087?lang=&edition=full","pubTime":"2021-11-26 17:18","market":"us","language":"en","title":"Travel stocks tumbled in premarket trading, RCL and CCL shares were down more than 12%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1192622087","media":"Tiger Newspress","summary":"Travel stocks tumbled in premarket trading, RCL and CCL shares were down more than 12%.\nBritain said","content":"<p>Travel&nbsp;stocks&nbsp;tumbled&nbsp;in&nbsp;premarket&nbsp;trading,&nbsp;RCL&nbsp;and&nbsp;CCL&nbsp;shares&nbsp;were&nbsp;down&nbsp;more&nbsp;than&nbsp;12%.</p>\n<p><img src=\"https://static.tigerbbs.com/dfc401660a371f57e567c34ce062949e\" tg-width=\"873\" tg-height=\"615\" referrerpolicy=\"no-referrer\">Britain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant <a href=\"https://laohu8.com/S/AONE.U\">one</a> yet found and so it needed to ascertain whether or not it made vaccines ineffective.</p>\n<p>Defending a ban on flights from South Africa, Namibia, Botswana, Zimbabwe, Lesotho and Eswatini, Transport Secretary Grant Shapps said that the lesson of COVID was that early action was essential.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Travel stocks tumbled in premarket trading, RCL and CCL shares were down more than 12%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTravel stocks tumbled in premarket trading, RCL and CCL shares were down more than 12%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Travel&nbsp;stocks&nbsp;tumbled&nbsp;in&nbsp;premarket&nbsp;trading,&nbsp;RCL&nbsp;and&nbsp;CCL&nbsp;shares&nbsp;were&nbsp;down&nbsp;more&nbsp;than&nbsp;12%.</p>\n<p><img src=\"https://static.tigerbbs.com/dfc401660a371f57e567c34ce062949e\" tg-width=\"873\" tg-height=\"615\" referrerpolicy=\"no-referrer\">Britain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant <a href=\"https://laohu8.com/S/AONE.U\">one</a> yet found and so it needed to ascertain whether or not it made vaccines ineffective.</p>\n<p>Defending a ban on flights from South Africa, Namibia, Botswana, Zimbabwe, Lesotho and Eswatini, Transport Secretary Grant Shapps said that the lesson of COVID was that early action was essential.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RCL":"皇家加勒比邮轮","CCL":"嘉年华邮轮"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192622087","content_text":"Travel stocks tumbled in premarket trading, RCL and CCL shares were down more than 12%.\nBritain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant one yet found and so it needed to ascertain whether or not it made vaccines ineffective.\nDefending a ban on flights from South Africa, Namibia, Botswana, Zimbabwe, Lesotho and Eswatini, Transport Secretary Grant Shapps said that the lesson of COVID was that early action was essential.","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877075315,"gmtCreate":1637852304189,"gmtModify":1637852304531,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Yes[强]&nbsp;[看涨]&nbsp;","listText":"Yes[强]&nbsp;[看涨]&nbsp;","text":"Yes[强] [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877075315","repostId":"2186916023","repostType":4,"repost":{"id":"2186916023","pubTimestamp":1637848500,"share":"https://www.laohu8.com/m/news/2186916023?lang=&edition=full","pubTime":"2021-11-25 21:55","market":"us","language":"en","title":"Will Palantir Be a Trillion-Dollar Stock by 2040?","url":"https://stock-news.laohu8.com/highlight/detail?id=2186916023","media":"Motley Fool","summary":"The data-mining firm has a slim chance of eventually joining the 12-zero club.","content":"<p><b>Palantir Technologies</b> (NYSE:PLTR) has been a volatile and polarizing investment since its direct listing last September. The bulls claimed its data-mining platforms would continue to grow as it signed more government and enterprise contracts.</p>\n<p>The bears pointed out that Palantir was too heavily dependent on government clients, its enterprise business faced too many competitors, it was deeply unprofitable, and its stock was too expensive.</p>\n<p>Palantir's stock price has experienced some wild swings over the past year, but it has still more than doubled since its first trade at $10 per share.</p>\n<p>Today, Palantir is valued at $41.3 billion, or 27 times this year's sales. The bears will argue that the high price-to-sales (P/S) ratio will limit its upside, especially as rising interest rates and inflation make many high-growth tech stocks less attractive.</p>\n<p>But let's look beyond the near-term noise and see if Palantir can still generate big multibagger gains, or even become a trillion-dollar stock, over the next two decades.</p>\n<h2>How fast is Palantir growing?</h2>\n<p>Palantir expects to grow its revenue by at least 30% annually between fiscal 2021 and 2025. That forecast implies its revenue will rise from its target of $1.5 billion this year to at least $4.3 billion in 2025.</p>\n<p>The company expects that growth to be driven by its new and expanded contracts with government agencies, as well as the growth of its Foundry platform for large commercial customers. The accelerating growth of its commercial business over the past year, which notably outpaced the growth of its government business last quarter, supports that thesis.</p>\n<h2>Palantir's path toward a trillion-dollar market cap</h2>\n<p>Palantir hasn't provided any longer-term targets beyond 2025. But based on the growth trajectory of other big data companies like <b><a href=\"https://laohu8.com/S/CRM\">Salesforce</a> </b>(NYSE:CRM), its annual revenue increase could potentially decelerate and stabilize at about 20% over the following 10 years.</p>\n<p>If it hits its target for 2025, then continues to grow its revenue at an average rate of 20% over the following 10 years, it could generate nearly $27 billion in revenue in 2035.</p>\n<p>If Palantir's revenue growth then slows down to 15% per year, which would be more comparable to <b>Microsoft</b>'s (NASDAQ:MSFT) current rate, it could generate over $53 billion in revenue in 2040.</p>\n<p>Assuming the company is still valued at over 20 times sales, its market cap could surpass $1 trillion. But most tech giants that grow their revenue 15% to 25% annually aren't valued at more than 20 times sales.</p>\n<p>Microsoft, which is expected to generate 17% sales growth this year, trades at 13 times that estimate. Salesforce, which is expected to generate 24% sales growth this year, trades at just 11 times this year's sales.</p>\n<p>Therefore, Palantir's market cap could potentially hit $1 trillion by 2040, but it seems highly unlikely. Instead, it will likely be closer to $500 billion (which would still be a 12-bagger gain from its current valuation) if its stock is trading at a more reasonable P/S ratio of 10.</p>\n<h2>Look beyond the market caps</h2>\n<p>Instead of focusing on Palantir's path toward joining the 12-zero club, investors should focus on its ability to generate sustainable growth.</p>\n<p>The company has gained a firm foothold with the U.S. government, but it still faces competition from internally developed systems. Immigration and Customs Enforcement (ICE), for example, has been developing its own platform to replace Palantir's Falcon. If other agencies follow ICE's lead, the company's dream of becoming the \"default operating system for data across the U.S. government\" could abruptly end.</p>\n<p>Palantir is making solid progress in the commercial market, but its Foundry platform still faces plenty of indirect competitors like <b>C3.ai</b>, <b>Salesforce</b>'s Tableau, and Glue from <b>Amazon</b> Web Services.</p>\n<p>The company likely believes its reputation as a battle-hardened platform for the U.S. military and government agencies will attract more enterprise customers. But there's no guarantee that this appeal will last for decades or fend off newer, hungrier, and more disruptive players in the data-mining market.</p>\n<h2>Is Palantir's stock still worth buying?</h2>\n<p>I still believe Palantir's stock is a promising long-term investment on the secular growth of the data-mining and analytics market. However, there's a lot of growth already baked into the stock, and its high valuations could limit its near-term and long-term potential. Palantir probably won't hit a trillion-dollar valuation within the next two decades, but it could still outperform the market and generate impressive multibagger gains.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Palantir Be a Trillion-Dollar Stock by 2040?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Palantir Be a Trillion-Dollar Stock by 2040?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/25/will-palantir-be-a-trillion-dollar-stock-by-2040/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies (NYSE:PLTR) has been a volatile and polarizing investment since its direct listing last September. The bulls claimed its data-mining platforms would continue to grow as it signed...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/25/will-palantir-be-a-trillion-dollar-stock-by-2040/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.fool.com/investing/2021/11/25/will-palantir-be-a-trillion-dollar-stock-by-2040/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186916023","content_text":"Palantir Technologies (NYSE:PLTR) has been a volatile and polarizing investment since its direct listing last September. The bulls claimed its data-mining platforms would continue to grow as it signed more government and enterprise contracts.\nThe bears pointed out that Palantir was too heavily dependent on government clients, its enterprise business faced too many competitors, it was deeply unprofitable, and its stock was too expensive.\nPalantir's stock price has experienced some wild swings over the past year, but it has still more than doubled since its first trade at $10 per share.\nToday, Palantir is valued at $41.3 billion, or 27 times this year's sales. The bears will argue that the high price-to-sales (P/S) ratio will limit its upside, especially as rising interest rates and inflation make many high-growth tech stocks less attractive.\nBut let's look beyond the near-term noise and see if Palantir can still generate big multibagger gains, or even become a trillion-dollar stock, over the next two decades.\nHow fast is Palantir growing?\nPalantir expects to grow its revenue by at least 30% annually between fiscal 2021 and 2025. That forecast implies its revenue will rise from its target of $1.5 billion this year to at least $4.3 billion in 2025.\nThe company expects that growth to be driven by its new and expanded contracts with government agencies, as well as the growth of its Foundry platform for large commercial customers. The accelerating growth of its commercial business over the past year, which notably outpaced the growth of its government business last quarter, supports that thesis.\nPalantir's path toward a trillion-dollar market cap\nPalantir hasn't provided any longer-term targets beyond 2025. But based on the growth trajectory of other big data companies like Salesforce (NYSE:CRM), its annual revenue increase could potentially decelerate and stabilize at about 20% over the following 10 years.\nIf it hits its target for 2025, then continues to grow its revenue at an average rate of 20% over the following 10 years, it could generate nearly $27 billion in revenue in 2035.\nIf Palantir's revenue growth then slows down to 15% per year, which would be more comparable to Microsoft's (NASDAQ:MSFT) current rate, it could generate over $53 billion in revenue in 2040.\nAssuming the company is still valued at over 20 times sales, its market cap could surpass $1 trillion. But most tech giants that grow their revenue 15% to 25% annually aren't valued at more than 20 times sales.\nMicrosoft, which is expected to generate 17% sales growth this year, trades at 13 times that estimate. Salesforce, which is expected to generate 24% sales growth this year, trades at just 11 times this year's sales.\nTherefore, Palantir's market cap could potentially hit $1 trillion by 2040, but it seems highly unlikely. Instead, it will likely be closer to $500 billion (which would still be a 12-bagger gain from its current valuation) if its stock is trading at a more reasonable P/S ratio of 10.\nLook beyond the market caps\nInstead of focusing on Palantir's path toward joining the 12-zero club, investors should focus on its ability to generate sustainable growth.\nThe company has gained a firm foothold with the U.S. government, but it still faces competition from internally developed systems. Immigration and Customs Enforcement (ICE), for example, has been developing its own platform to replace Palantir's Falcon. If other agencies follow ICE's lead, the company's dream of becoming the \"default operating system for data across the U.S. government\" could abruptly end.\nPalantir is making solid progress in the commercial market, but its Foundry platform still faces plenty of indirect competitors like C3.ai, Salesforce's Tableau, and Glue from Amazon Web Services.\nThe company likely believes its reputation as a battle-hardened platform for the U.S. military and government agencies will attract more enterprise customers. But there's no guarantee that this appeal will last for decades or fend off newer, hungrier, and more disruptive players in the data-mining market.\nIs Palantir's stock still worth buying?\nI still believe Palantir's stock is a promising long-term investment on the secular growth of the data-mining and analytics market. However, there's a lot of growth already baked into the stock, and its high valuations could limit its near-term and long-term potential. Palantir probably won't hit a trillion-dollar valuation within the next two decades, but it could still outperform the market and generate impressive multibagger gains.","news_type":1},"isVote":1,"tweetType":1,"viewCount":184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874837147,"gmtCreate":1637755001160,"gmtModify":1637755001476,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Nice[强]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;","listText":"Nice[强]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;","text":"Nice[强] [看涨] [梭哈] [美金]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874837147","repostId":"1186881303","repostType":4,"repost":{"id":"1186881303","pubTimestamp":1637754802,"share":"https://www.laohu8.com/m/news/1186881303?lang=&edition=full","pubTime":"2021-11-24 19:53","market":"us","language":"en","title":"Xpeng Aims To Sell Nearly As Many Electric Vehicles Overseas As In China","url":"https://stock-news.laohu8.com/highlight/detail?id=1186881303","media":"Benzinga","summary":"Chinese electric vehicle maker Xpeng Inc aims to sell half of its electric vehicle outside China, CN","content":"<p>Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>&nbsp;aims to sell half of its electric vehicle outside China, CNBC reported, citing the company’s president and chairman Brian Gu.</p>\n<p><b>What Happened:</b>Xpeng already sells electric vehicles in Norway and plans to ramp up investment overseas next year including foraying into Sweden, Denmark and the Netherlands in 2022.</p>\n<p>The Guangzhou, China-based Xpeng did not provide a timeline or provide more details.</p>\n<p>Xpeng had in August announced it would double the production capacity from 100,000 to 200,000 electric cars annually.</p>\n<p><b>Why It Matters:</b>&nbsp;Xpeng revealed an&nbsp;<b>electric SUV G9</b>— its fourth electric vehicle — equipped with its in-house Xpilot semi-autonomous driving system and the lidar technology last week. The automaker plans to sell G9 in both China and overseas.</p>\n<p>The G9 is expected to compete with&nbsp;<b>Nio Inc</b>’s ES6 an&nbsp;<b>Tesla Inc’s</b>&nbsp;Model Y.Nio, Xpeng and&nbsp;<b>BYD Co</b>&nbsp;are among Chinese electric vehicle makers that are eyeing overseas expansion after successfully establishing their brands on home turf.</p>\n<p><b>Price Action:</b>&nbsp;Xpeng shares closed 8.25% higher at $51.30 a share on Wednesday after it&nbsp;reported&nbsp;third-quarter numbers.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xpeng Aims To Sell Nearly As Many Electric Vehicles Overseas As In China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXpeng Aims To Sell Nearly As Many Electric Vehicles Overseas As In China\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-24 19:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24268896/xpeng-aims-to-sell-nearly-as-many-electric-vehicles-overseas-as-in-china><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chinese electric vehicle maker Xpeng Inc aims to sell half of its electric vehicle outside China, CNBC reported, citing the company’s president and chairman Brian Gu.\nWhat Happened:Xpeng already sells...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24268896/xpeng-aims-to-sell-nearly-as-many-electric-vehicles-overseas-as-in-china\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车"},"source_url":"https://www.benzinga.com/news/21/11/24268896/xpeng-aims-to-sell-nearly-as-many-electric-vehicles-overseas-as-in-china","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186881303","content_text":"Chinese electric vehicle maker Xpeng Inc aims to sell half of its electric vehicle outside China, CNBC reported, citing the company’s president and chairman Brian Gu.\nWhat Happened:Xpeng already sells electric vehicles in Norway and plans to ramp up investment overseas next year including foraying into Sweden, Denmark and the Netherlands in 2022.\nThe Guangzhou, China-based Xpeng did not provide a timeline or provide more details.\nXpeng had in August announced it would double the production capacity from 100,000 to 200,000 electric cars annually.\nWhy It Matters: Xpeng revealed an electric SUV G9— its fourth electric vehicle — equipped with its in-house Xpilot semi-autonomous driving system and the lidar technology last week. The automaker plans to sell G9 in both China and overseas.\nThe G9 is expected to compete with Nio Inc’s ES6 an Tesla Inc’s Model Y.Nio, Xpeng and BYD Co are among Chinese electric vehicle makers that are eyeing overseas expansion after successfully establishing their brands on home turf.\nPrice Action: Xpeng shares closed 8.25% higher at $51.30 a share on Wednesday after it reported third-quarter numbers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":607365077,"gmtCreate":1639491666213,"gmtModify":1639491717114,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"ABBV[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;","listText":"ABBV[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;","text":"ABBV[Allin] [USD] [Call] [Call] [Like]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607365077","repostId":"2191930972","repostType":4,"repost":{"id":"2191930972","pubTimestamp":1639489168,"share":"https://www.laohu8.com/m/news/2191930972?lang=&edition=full","pubTime":"2021-12-14 21:39","market":"us","language":"en","title":"2 Warren Buffett Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191930972","media":"Motley Fool","summary":"AbbVie and Royalty Pharma should be on every dividend investor's radar right now.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.</p>\n<p>As a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.</p>\n<p>Which Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks <b>AbbVie</b> (NYSE:ABBV) and <b>Royalty Pharma</b> (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.</p>\n<h2>AbbVie: A high-yield growth stock</h2>\n<p>Berkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest yields among major drug manufacturers.</p>\n<p>Second, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.</p>\n<p>Lastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.</p>\n<p>The net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.</p>\n<h2>Royalty Pharma: A dependable revenue stream</h2>\n<p>Royalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.</p>\n<p><img src=\"https://static.tigerbbs.com/a320f51af9bb7ac0d6359af7ed64161a\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>RPRX data by YCharts</p>\n<p>Why is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.</p>\n<p>Now, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Dividend Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Dividend Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BRK.A":"伯克希尔","BK4007":"制药","RPRX":"Royalty Pharma plc","BRK.B":"伯克希尔B","BK4566":"资本集团","BK4139":"生物科技","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BK4176":"多领域控股"},"source_url":"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191930972","content_text":"Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.\nAs a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.\nWhich Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks AbbVie (NYSE:ABBV) and Royalty Pharma (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.\nAbbVie: A high-yield growth stock\nBerkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's one of the highest yields among major drug manufacturers.\nSecond, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.\nLastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.\nThe net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.\nRoyalty Pharma: A dependable revenue stream\nRoyalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.\n\nRPRX data by YCharts\nWhy is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.\nNow, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.","news_type":1},"isVote":1,"tweetType":1,"viewCount":606,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600786960,"gmtCreate":1638197990281,"gmtModify":1638197995468,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[冷漠]&nbsp;[可怜]&nbsp;[叹气]&nbsp;[疑问]&nbsp;[心碎]&nbsp;","listText":"[冷漠]&nbsp;[可怜]&nbsp;[叹气]&nbsp;[疑问]&nbsp;[心碎]&nbsp;","text":"[冷漠] [可怜] [叹气] [疑问] [心碎]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600786960","repostId":"1137393357","repostType":2,"repost":{"id":"1137393357","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638197348,"share":"https://www.laohu8.com/m/news/1137393357?lang=&edition=full","pubTime":"2021-11-29 22:49","market":"us","language":"en","title":"Merck stock dipped more than 4% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137393357","media":"Tiger Newspress","summary":"Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi ","content":"<p>Merck stock dipped more than 4% in morning trading&nbsp;as&nbsp;it&nbsp;was downgraded to neutral from buy by Citi Research.</p>\n<p><img src=\"https://static.tigerbbs.com/921cc70c00deb0f565b98bc2a7218479\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Disappointing results for some major drugs has limited the upside for&nbsp;Merck’s stock, according to Citi.</p>\n<p>Analyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.</p>\n<p>“Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.</p>\n<p>Citi cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck stock dipped more than 4% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck stock dipped more than 4% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-29 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Merck stock dipped more than 4% in morning trading&nbsp;as&nbsp;it&nbsp;was downgraded to neutral from buy by Citi Research.</p>\n<p><img src=\"https://static.tigerbbs.com/921cc70c00deb0f565b98bc2a7218479\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Disappointing results for some major drugs has limited the upside for&nbsp;Merck’s stock, according to Citi.</p>\n<p>Analyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.</p>\n<p>“Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.</p>\n<p>Citi cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137393357","content_text":"Merck stock dipped more than 4% in morning trading as it was downgraded to neutral from buy by Citi Research.\n\nDisappointing results for some major drugs has limited the upside for Merck’s stock, according to Citi.\nAnalyst Andrew Baum downgraded Merck to neutral from buy, saying in a note to clients on Monday that development struggles for the company’s HIV drug islatravir was taking a bite out of Merck’s long-term potential.\n“Our long-standing investment thesis on MRK was based on underappreciation of MRK’s pipeline, especially islatravir for HIV to help to offset the forthcoming Keytruda [loss of exclusivity] ... We have removed our $4bn risk adjusted 2030 estimate from our model, reducing our EPS estimates up to 10%,” the note said.\nCiti cut its price target on Merck to $85 per share from $105. The new target is about 7% above where the stock closed on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871402517,"gmtCreate":1637103014936,"gmtModify":1637103015917,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;[保佑]&nbsp;","listText":"[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;[保佑]&nbsp;","text":"[强] [看涨] [看涨] [梭哈] [美金] [保佑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871402517","repostId":"1105128454","repostType":4,"repost":{"id":"1105128454","pubTimestamp":1637075732,"share":"https://www.laohu8.com/m/news/1105128454?lang=&edition=full","pubTime":"2021-11-16 23:15","market":"us","language":"en","title":"Rivian Leaps Past Volkswagen’s Valuation as EV Mania Rages","url":"https://stock-news.laohu8.com/highlight/detail?id=1105128454","media":"Bloomberg","summary":"A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup ","content":"<p>A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup to more than double in value since last-week’s trading debut, with its market capitalization now surpassing Volkswagen AG.</p>\n<p>The stock jumped as much as 10% to $164.60 in New York on Tuesday, up 111% from the initial public offering price of $78. That brought the company’s market valuation to $143.5 billion, easily topping the list of biggest U.S. companies with no sales.</p>\n<p>Rivian, which is backed by Amazon and Ford, overtook Volkswagen’s market capitalization of $138.9 billion, as investors eager to get into the EV sector now have another stock to invest in, apart from industry trailblazer Tesla Inc.</p>\n<p>The rally since its IPO also makes Rivian’s the year’s second-best debut week, behind Affirm Holdings Inc., which gained 117% during its first five sessions. This data excludes IPOs that raised less than $1 billion.</p>\n<p>EV stocks of all stripes and colors have also seen heightened interest from retail investors in recent weeks, with Rivian, Lucid and Tesla topping Fidelity’s retail trading platform’s list of most bought assets on Tuesday.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rivian Leaps Past Volkswagen’s Valuation as EV Mania Rages</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRivian Leaps Past Volkswagen’s Valuation as EV Mania Rages\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/rivian-leaps-past-volkswagen-valuation-145011593.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup to more than double in value since last-week’s trading debut, with its market capitalization now ...</p>\n\n<a href=\"https://finance.yahoo.com/news/rivian-leaps-past-volkswagen-valuation-145011593.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc."},"source_url":"https://finance.yahoo.com/news/rivian-leaps-past-volkswagen-valuation-145011593.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105128454","content_text":"A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup to more than double in value since last-week’s trading debut, with its market capitalization now surpassing Volkswagen AG.\nThe stock jumped as much as 10% to $164.60 in New York on Tuesday, up 111% from the initial public offering price of $78. That brought the company’s market valuation to $143.5 billion, easily topping the list of biggest U.S. companies with no sales.\nRivian, which is backed by Amazon and Ford, overtook Volkswagen’s market capitalization of $138.9 billion, as investors eager to get into the EV sector now have another stock to invest in, apart from industry trailblazer Tesla Inc.\nThe rally since its IPO also makes Rivian’s the year’s second-best debut week, behind Affirm Holdings Inc., which gained 117% during its first five sessions. This data excludes IPOs that raised less than $1 billion.\nEV stocks of all stripes and colors have also seen heightened interest from retail investors in recent weeks, with Rivian, Lucid and Tesla topping Fidelity’s retail trading platform’s list of most bought assets on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698544852,"gmtCreate":1640480395781,"gmtModify":1640480396640,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[USD]&nbsp;[Allin]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","listText":"[USD]&nbsp;[Allin]&nbsp;[Call]&nbsp;[Like]&nbsp;[Bless]&nbsp;","text":"[USD] [Allin] [Call] [Like] [Bless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698544852","repostId":"2194171798","repostType":4,"repost":{"id":"2194171798","pubTimestamp":1640480255,"share":"https://www.laohu8.com/m/news/2194171798?lang=&edition=full","pubTime":"2021-12-26 08:57","market":"us","language":"en","title":"1 Retail Stock That Can Go Head-to-Head With E-Commerce","url":"https://stock-news.laohu8.com/highlight/detail?id=2194171798","media":"Motley Fool","summary":"This company aced its pivot to omnichannel retail.","content":"<p>It wasn't too long ago that <b>Best Buy</b>'s (NYSE:BBY) viability was in doubt. E-commerce retailers like <b>Amazon</b> (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up well to compete. In this <i>Fool Live</i> video clip,&nbsp;<b>recorded on Dec. 13,&nbsp;</b>Fool.com contributors Jason Hall and Danny Vena discuss Best Buy's impressive transformation and what could be ahead.</p>\n<p><b>Jason Hall:</b> This company is an absolute survivor. You go back to the early 2000s when Best Buy was really just emerging as a national player. What a lot of people don't know is that the company almost got put out of business for bait-and-switch tactics because they had a high-pressure commission salesforce, and they were baiting and switching. And the company, they still deny that, but the reality is that's what they were doing.</p>\n<p>They came away from it, they dropped their entire sales staff to hourly, changed the model completely. Coincided with the birth of the internet and people not really needing to find a salesperson to explain the difference between two dryers anymore -- that's what the internet is for. They revolutionized their business and went on a 10-year raging growth path. Then the internet started to become the enemy of the business, as Matt was talking about. Then they were able to pivot with their omnichannel. That's worked really well.</p>\n<p>I think just right now, they're dealing with the fact that everything they sell has a semiconductor in it. There's not enough of those around anymore. If that's a problem in the near term. But I think it's an opportunity in the long term because everything they sell has a semiconductor in it, that means they are selling the things that people want. I think it fits right in the middle of this pack. It's a good, strong business. It's a survivor, probably not a market beater, market killer anyway, probably a run-at-market-perform business. But I think it's pretty well positioned.</p>\n<p><b>Danny Vena:</b> Yes, this is a company that I voted probably the high end of middle of the pack. I voted this No. 4 [out of 10 \"holiday shopping\" stocks]. For me, I think one of the more overlooked things about Best Buy, and I absolutely agree with everything that Jason said and the fact that the company has done remarkably well at doing the omnichannel business during the pandemic. They had folks order stuff online, pickup in store so they could get it right away. They were able to tap into that remote work from home, trends that happened.</p>\n<p>I think one of the most overlooked things about what Best Buy has done is they have introduced essentially a subscription program. They already had one where you could pay $199 a year and you could bring in your computer and have them diagnosis it. They could add software, they could do a lot of things. Now, they have changed that to where you get unlimited calls with Geek Squad. They will help you with essentially anything having to do with electronics. That I think is going to be a high-margin business. I think it's going to lift their margins. I think it gives them an opportunity to keep their brand front of mind with consumers.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Retail Stock That Can Go Head-to-Head With E-Commerce</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Retail Stock That Can Go Head-to-Head With E-Commerce\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 08:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It wasn't too long ago that Best Buy's (NYSE:BBY) viability was in doubt. E-commerce retailers like Amazon (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4561":"索罗斯持仓","BK4548":"巴美列捷福持仓","BK4532":"文艺复兴科技持仓","BBY":"百思买","BK4554":"元宇宙及AR概念","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4550":"红杉资本持仓","BK4076":"电脑与电子产品零售","AMZN":"亚马逊","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194171798","content_text":"It wasn't too long ago that Best Buy's (NYSE:BBY) viability was in doubt. E-commerce retailers like Amazon (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up well to compete. In this Fool Live video clip, recorded on Dec. 13, Fool.com contributors Jason Hall and Danny Vena discuss Best Buy's impressive transformation and what could be ahead.\nJason Hall: This company is an absolute survivor. You go back to the early 2000s when Best Buy was really just emerging as a national player. What a lot of people don't know is that the company almost got put out of business for bait-and-switch tactics because they had a high-pressure commission salesforce, and they were baiting and switching. And the company, they still deny that, but the reality is that's what they were doing.\nThey came away from it, they dropped their entire sales staff to hourly, changed the model completely. Coincided with the birth of the internet and people not really needing to find a salesperson to explain the difference between two dryers anymore -- that's what the internet is for. They revolutionized their business and went on a 10-year raging growth path. Then the internet started to become the enemy of the business, as Matt was talking about. Then they were able to pivot with their omnichannel. That's worked really well.\nI think just right now, they're dealing with the fact that everything they sell has a semiconductor in it. There's not enough of those around anymore. If that's a problem in the near term. But I think it's an opportunity in the long term because everything they sell has a semiconductor in it, that means they are selling the things that people want. I think it fits right in the middle of this pack. It's a good, strong business. It's a survivor, probably not a market beater, market killer anyway, probably a run-at-market-perform business. But I think it's pretty well positioned.\nDanny Vena: Yes, this is a company that I voted probably the high end of middle of the pack. I voted this No. 4 [out of 10 \"holiday shopping\" stocks]. For me, I think one of the more overlooked things about Best Buy, and I absolutely agree with everything that Jason said and the fact that the company has done remarkably well at doing the omnichannel business during the pandemic. They had folks order stuff online, pickup in store so they could get it right away. They were able to tap into that remote work from home, trends that happened.\nI think one of the most overlooked things about what Best Buy has done is they have introduced essentially a subscription program. They already had one where you could pay $199 a year and you could bring in your computer and have them diagnosis it. They could add software, they could do a lot of things. Now, they have changed that to where you get unlimited calls with Geek Squad. They will help you with essentially anything having to do with electronics. That I think is going to be a high-margin business. I think it's going to lift their margins. I think it gives them an opportunity to keep their brand front of mind with consumers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693498078,"gmtCreate":1640057094513,"gmtModify":1640057928006,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[USD]&nbsp;[Allin]&nbsp;[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;","listText":"[USD]&nbsp;[Allin]&nbsp;[Like]&nbsp;[Call]&nbsp;[Call]&nbsp;","text":"[USD] [Allin] [Like] [Call] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693498078","repostId":"1112391676","repostType":4,"repost":{"id":"1112391676","pubTimestamp":1640056217,"share":"https://www.laohu8.com/m/news/1112391676?lang=&edition=full","pubTime":"2021-12-21 11:10","market":"us","language":"en","title":"Apple Stock: If You're Buying the Dip, Here's What You Need to Know","url":"https://stock-news.laohu8.com/highlight/detail?id=1112391676","media":"TheStreet","summary":"Bargain hunters may start to consider buying Apple stock on the dip, following the December selloff. Here is what they should know first.Apple stock remains in a funk. Only one week to the dayafter I tossed around the ideaof trimming the position, shares of the Cupertino company dipped 7% from the $180 peak against the Nasdaq’s 4% decline, nearly entering correction territory.A few brave investors and traders must be taking this opportunity to start buying the dip. The Apple Maven highlights thr","content":"<p>Bargain hunters may start to consider buying Apple stock on the dip, following the December selloff. Here is what they should know first.</p>\n<p>Apple stock&nbsp;remains in a funk. Only one week to the dayafter I tossed around the ideaof trimming the position, shares of the Cupertino company dipped 7% from the $180 peak against the Nasdaq’s 4% decline, nearly entering correction territory.</p>\n<p>A few brave investors and traders must be taking this opportunity to start buying the dip. The Apple Maven highlights three facts that these bargain hunters should keep in mind.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a182a349bbd4ca16a13dace221ec341e\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple store in China.</span></p>\n<p><b>#1. Valuations are looking more attractive</b></p>\n<p>AAPL is far from being a dirt cheap stock. The price-to-earnings ratio today is still higher than it had been for at least the full decade prior to the start of the pandemic (see chart below). However, with the recent decline in share price but still resilient business fundamentals, valuations are starting to look more compelling.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/75ae50cce66d14520a3db0ce721b79a3\" tg-width=\"827\" tg-height=\"389\" width=\"100%\" height=\"auto\"><span>Figure 2: AAPL's historical price-to-earnings ratio.</span></p>\n<p>The last read on the graph above shows a P/E of 29.0 times as of November 30. As of last check, on December 20, the fiscal 2022 multiple had dropped to 27.5 times. These are roughly the same levels of June 2020, after which Apple stock moved 85% higher in a year and a half.</p>\n<p><b>#2. The deeper the hole, the higher the gains</b></p>\n<p>“Buy low, sell high”. The mantra may seem overly simplistic, but the strategy has worked wonders in the case of AAPL.</p>\n<p>We have often mentioned here, on the Apple Maven channel, that shares of the Cupertino company&nbsp;do best when bought after a selloff. Historically, the one-year gains have been 22% when the stock is bought near a peak, but nearly 40% when bought after a 15% drawdown.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9439be7d48cbf04254a822d9d57576f3\" tg-width=\"601\" tg-height=\"361\" width=\"100%\" height=\"auto\"><span>Figure 3: Average one-year return on AAPL, by strategy.</span></p>\n<p>Could this time be different for dip buyers? I think not. To be clear, I do not believe that every stock is worth owning on weakness, as “40% of all stocks have&nbsp;suffered&nbsp;a permanent 70%-plus decline from their peak value”.</p>\n<p>But in the case of Apple, it is highly likely that share price will eventually head higher again, shaking off short-term bearishness and chasing the strong business fundamentals. Having the patience to wait for the next rally is crucial.</p>\n<p><b>#3. Don’t underestimate volatility</b></p>\n<p>All the above sounds bullish at first glance, and an incentive to buy Apple at the current share price of around $168. But if doing so, I urge traders and investors to pay attention to volatility.</p>\n<p>The emotional and psychological aspects of investing can be as important as the quantitative considerations, in my view. Those who buy dips must be willing to endure higher volatility, which has increased sharply for AAPL in the past few weeks — see below.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eace3c9293acb54a4dc217debd6a44be\" tg-width=\"618\" tg-height=\"370\" width=\"100%\" height=\"auto\"><span>Figure 4: Annual volatility in AAPL, 1-month rolling.</span></p>\n<p>Because Apple stock price is likely to ricochet in the short term, some might be tempted to sell their shares prematurely, should they drop well below current levels. If buying AAPL, be sure to have a clear exit strategy to avoid falling victim to spur-of-the-moment decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: If You're Buying the Dip, Here's What You Need to Know</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: If You're Buying the Dip, Here's What You Need to Know\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 11:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-3-key-facts-dip-buyers-must-know><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bargain hunters may start to consider buying Apple stock on the dip, following the December selloff. Here is what they should know first.\nApple stock remains in a funk. Only one week to the dayafter I...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-3-key-facts-dip-buyers-must-know\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-3-key-facts-dip-buyers-must-know","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112391676","content_text":"Bargain hunters may start to consider buying Apple stock on the dip, following the December selloff. Here is what they should know first.\nApple stock remains in a funk. Only one week to the dayafter I tossed around the ideaof trimming the position, shares of the Cupertino company dipped 7% from the $180 peak against the Nasdaq’s 4% decline, nearly entering correction territory.\nA few brave investors and traders must be taking this opportunity to start buying the dip. The Apple Maven highlights three facts that these bargain hunters should keep in mind.\nFigure 1: Apple store in China.\n#1. Valuations are looking more attractive\nAAPL is far from being a dirt cheap stock. The price-to-earnings ratio today is still higher than it had been for at least the full decade prior to the start of the pandemic (see chart below). However, with the recent decline in share price but still resilient business fundamentals, valuations are starting to look more compelling.\nFigure 2: AAPL's historical price-to-earnings ratio.\nThe last read on the graph above shows a P/E of 29.0 times as of November 30. As of last check, on December 20, the fiscal 2022 multiple had dropped to 27.5 times. These are roughly the same levels of June 2020, after which Apple stock moved 85% higher in a year and a half.\n#2. The deeper the hole, the higher the gains\n“Buy low, sell high”. The mantra may seem overly simplistic, but the strategy has worked wonders in the case of AAPL.\nWe have often mentioned here, on the Apple Maven channel, that shares of the Cupertino company do best when bought after a selloff. Historically, the one-year gains have been 22% when the stock is bought near a peak, but nearly 40% when bought after a 15% drawdown.\nFigure 3: Average one-year return on AAPL, by strategy.\nCould this time be different for dip buyers? I think not. To be clear, I do not believe that every stock is worth owning on weakness, as “40% of all stocks have suffered a permanent 70%-plus decline from their peak value”.\nBut in the case of Apple, it is highly likely that share price will eventually head higher again, shaking off short-term bearishness and chasing the strong business fundamentals. Having the patience to wait for the next rally is crucial.\n#3. Don’t underestimate volatility\nAll the above sounds bullish at first glance, and an incentive to buy Apple at the current share price of around $168. But if doing so, I urge traders and investors to pay attention to volatility.\nThe emotional and psychological aspects of investing can be as important as the quantitative considerations, in my view. Those who buy dips must be willing to endure higher volatility, which has increased sharply for AAPL in the past few weeks — see below.\nFigure 4: Annual volatility in AAPL, 1-month rolling.\nBecause Apple stock price is likely to ricochet in the short term, some might be tempted to sell their shares prematurely, should they drop well below current levels. If buying AAPL, be sure to have a clear exit strategy to avoid falling victim to spur-of-the-moment decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":556,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607894148,"gmtCreate":1639522772006,"gmtModify":1639522772840,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Like]&nbsp;[Heart]&nbsp;","listText":"[Like]&nbsp;[Heart]&nbsp;","text":"[Like] [Heart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607894148","repostId":"2191937155","repostType":4,"repost":{"id":"2191937155","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639521474,"share":"https://www.laohu8.com/m/news/2191937155?lang=&edition=full","pubTime":"2021-12-15 06:37","market":"us","language":"en","title":"Pfizer says COVID-19 pill near 90% protective against hospitalization, death","url":"https://stock-news.laohu8.com/highlight/detail?id=2191937155","media":"Reuters","summary":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% ","content":"<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says COVID-19 pill near 90% protective against hospitalization, death</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says COVID-19 pill near 90% protective against hospitalization, death\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BK4007":"制药","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191937155","content_text":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.\nThe U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.\nNobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.\nThe Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.\n\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.\n\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.\nPfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.\nPfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.\nDolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.\n\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.\n'VERY EXCITING RESULTS'\nPfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.\nPaxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS\n\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.\nSax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.\nThere are currently no oral antiviral treatments for COVID-9 authorized in the United States.\nAnalysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.\nRival Merck & Co has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.\nSome scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.\nPfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.\nRecent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.\nThe company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.\nDolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.\nPfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.\nThe MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.\nThe U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":706,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876353006,"gmtCreate":1637276135422,"gmtModify":1637276135748,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[强]&nbsp;[看涨]&nbsp;","listText":"[强]&nbsp;[看涨]&nbsp;","text":"[强] [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876353006","repostId":"1101595929","repostType":4,"repost":{"id":"1101595929","pubTimestamp":1637249279,"share":"https://www.laohu8.com/m/news/1101595929?lang=&edition=full","pubTime":"2021-11-18 23:27","market":"us","language":"en","title":"Amazon, BofA Could Owe More Under a New Corporate-Minimum Tax","url":"https://stock-news.laohu8.com/highlight/detail?id=1101595929","media":"Bloomberg","summary":"More than 70 companies could pay new 15% corporate minimum tax\nHouse to vote as soon as Thursday on ","content":"<ul>\n <li>More than 70 companies could pay new 15% corporate minimum tax</li>\n <li>House to vote as soon as Thursday on Biden economic bill</li>\n</ul>\n<p>Amazon.com Inc.,Bank of America Corp.&nbsp;and&nbsp;DISH Network Corp.&nbsp;are among the companies that likely would owe more in taxes if Congress passes a new corporate minimum levy, according to an analysis.</p>\n<p>Senator Elizabeth Warren, a Massachusetts Democrat, who helped draft the proposal for minimum tax on corporate profits in President Joe Biden’s economic agenda, released an&nbsp;analysis&nbsp;Thursday that found that at least 70 companies would pay more in taxes under the plan, based on their earnings in 2020.</p>\n<p>The corporate minimum levy in the tax-and-spending plan would require companies earn at least $1 billion in financial, or “book,” profits to pay a minimum tax rate of at least 15%. The proposal is meant to target profitable companies that are able to slash their tax bills because they qualify for tax deductions and credits to whittle down their Internal Revenue Service liabilities.</p>\n<p>Amazon would have had to pay an additional $836 million, based on its reported profits and tax payments, while Bank of America would have paid $1.1 billion more, had the corporate minimum tax been in effect in 2020, the analysis concluded. DISH, which received a $223 million tax refund last year, would have ended up owing $386 million to U.S. and foreign governments on its $2.6 billion in global profits, according to the report.</p>\n<p>“Billionaire corporations have gotten a free ride in America for too long. It’s time to stop letting giant corporations cheat the system -- they should pay taxes just like everyone else,” Warren said in a statement.</p>\n<p>The corporate minimum tax would raise about $318.9 billion over a decade, accounting for more than 20% of the $1.5 trillion in tax increases in the legislation, which the House could vote on as soon as Thursday. The bill will then likely undergo revisions in the Senate.</p>\n<p>The minimum tax is a roundabout way of raising corporate taxes without touching the 21% corporate tax rate, which Senator Kyrsten Sinema, an Arizona Democrat whose vote is crucial in the evenly divided Senate, has said she opposes. The measure has been criticized by some economists, companies, and even House Ways and Means Chairman Richard Neal for adding complexity to the already dense tax code.</p>\n<p>Financial companies, banks, telecommunications companies and utilities are likely to bear the brunt of the corporate minimum tax, according to Morgan Stanley Research led by Todd Castagno. Collectively companies in those industries will pay about 60% of the estimated book tax liability, according to Morgan Stanley.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon, BofA Could Owe More Under a New Corporate-Minimum Tax</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon, BofA Could Owe More Under a New Corporate-Minimum Tax\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-18/amazon-bank-of-america-could-get-tangled-in-new-corporate-tax?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>More than 70 companies could pay new 15% corporate minimum tax\nHouse to vote as soon as Thursday on Biden economic bill\n\nAmazon.com Inc.,Bank of America Corp. and DISH Network Corp. are among the ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-18/amazon-bank-of-america-could-get-tangled-in-new-corporate-tax?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BAC":"美国银行","AMZN":"亚马逊"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-18/amazon-bank-of-america-could-get-tangled-in-new-corporate-tax?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101595929","content_text":"More than 70 companies could pay new 15% corporate minimum tax\nHouse to vote as soon as Thursday on Biden economic bill\n\nAmazon.com Inc.,Bank of America Corp. and DISH Network Corp. are among the companies that likely would owe more in taxes if Congress passes a new corporate minimum levy, according to an analysis.\nSenator Elizabeth Warren, a Massachusetts Democrat, who helped draft the proposal for minimum tax on corporate profits in President Joe Biden’s economic agenda, released an analysis Thursday that found that at least 70 companies would pay more in taxes under the plan, based on their earnings in 2020.\nThe corporate minimum levy in the tax-and-spending plan would require companies earn at least $1 billion in financial, or “book,” profits to pay a minimum tax rate of at least 15%. The proposal is meant to target profitable companies that are able to slash their tax bills because they qualify for tax deductions and credits to whittle down their Internal Revenue Service liabilities.\nAmazon would have had to pay an additional $836 million, based on its reported profits and tax payments, while Bank of America would have paid $1.1 billion more, had the corporate minimum tax been in effect in 2020, the analysis concluded. DISH, which received a $223 million tax refund last year, would have ended up owing $386 million to U.S. and foreign governments on its $2.6 billion in global profits, according to the report.\n“Billionaire corporations have gotten a free ride in America for too long. It’s time to stop letting giant corporations cheat the system -- they should pay taxes just like everyone else,” Warren said in a statement.\nThe corporate minimum tax would raise about $318.9 billion over a decade, accounting for more than 20% of the $1.5 trillion in tax increases in the legislation, which the House could vote on as soon as Thursday. The bill will then likely undergo revisions in the Senate.\nThe minimum tax is a roundabout way of raising corporate taxes without touching the 21% corporate tax rate, which Senator Kyrsten Sinema, an Arizona Democrat whose vote is crucial in the evenly divided Senate, has said she opposes. The measure has been criticized by some economists, companies, and even House Ways and Means Chairman Richard Neal for adding complexity to the already dense tax code.\nFinancial companies, banks, telecommunications companies and utilities are likely to bear the brunt of the corporate minimum tax, according to Morgan Stanley Research led by Todd Castagno. Collectively companies in those industries will pay about 60% of the estimated book tax liability, according to Morgan Stanley.","news_type":1},"isVote":1,"tweetType":1,"viewCount":58,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826159849,"gmtCreate":1633998764449,"gmtModify":1633998764652,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[强]&nbsp;","listText":"[强]&nbsp;","text":"[强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/826159849","repostId":"1182231637","repostType":4,"repost":{"id":"1182231637","pubTimestamp":1633997775,"share":"https://www.laohu8.com/m/news/1182231637?lang=&edition=full","pubTime":"2021-10-12 08:16","market":"us","language":"en","title":"Amazon CEO Jassy revises company's return-to-office guidelines","url":"https://stock-news.laohu8.com/highlight/detail?id=1182231637","media":"seekingalpha","summary":"As Amazon(NASDAQ:AMZN)proceeds with plans to have employees return to their offices early next year,","content":"<ul>\n <li>As Amazon(NASDAQ:AMZN)proceeds with plans to have employees return to their offices early next year, the company is also offering up more flexibility for corporate employees to continue working from home.</li>\n <li>Amazon (AMZN) Chief Executive Andy Jassy outlined the company's new plans&nbsp;in a letter sent to company employees on Monday. In the letter, addressed to Amazon's \"Amazonians\", Jassy said that individual team directors will have the final say regarding how many days a week their staffs will need to be in the office when the company re-opens its U.S. corporate locations. Amazon (AMZN) is currently expecting employees to come back to the Seattle headquarters, and other locations, starting Jan. 3, 2022.</li>\n <li>The company--which has more than 1 million employees around the world--was expecting to require all corporate workers to come in to their offices at least three days a week beginning in January. However, Jassy said that having most of its staff working remotely due the Covid-19 pandemic led Amazon to re-evaluate its philosophy about workers needing to be in the office at all times.</li>\n <li>\"At a company of our size, there is no one-size-fits-all approach for how every team works best,\" Jassy said. \"We are intentionally not prescribing how many days or which days [for employees to be in the office]. This is for directors to determine with their senior leaders and teams.\"</li>\n <li>Jassy said that he doesn't believe all of Amazon's corporate will be working remotely on a full-time basis.</li>\n <li>\"We expect that there will be teams that continue working mostly remotely, others that will work some combination of remotely and in the office, and still others that will decide customers are best served having the team work mostly in the office,\" Jassy said.</li>\n <li>Amazon (AMZN) had originally intended to re-open its offices in September, but a spike in Covid cases due to the rise of the Delta variant of the virus led it,and many other leading tech companies, to delay their plans until early 2022.</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon CEO Jassy revises company's return-to-office guidelines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon CEO Jassy revises company's return-to-office guidelines\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-12 08:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3751379-amazon-ceo-jassy-revises-companys-return-to-office-guidelines><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As Amazon(NASDAQ:AMZN)proceeds with plans to have employees return to their offices early next year, the company is also offering up more flexibility for corporate employees to continue working from ...</p>\n\n<a href=\"https://seekingalpha.com/news/3751379-amazon-ceo-jassy-revises-companys-return-to-office-guidelines\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://seekingalpha.com/news/3751379-amazon-ceo-jassy-revises-companys-return-to-office-guidelines","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1182231637","content_text":"As Amazon(NASDAQ:AMZN)proceeds with plans to have employees return to their offices early next year, the company is also offering up more flexibility for corporate employees to continue working from home.\nAmazon (AMZN) Chief Executive Andy Jassy outlined the company's new plans in a letter sent to company employees on Monday. In the letter, addressed to Amazon's \"Amazonians\", Jassy said that individual team directors will have the final say regarding how many days a week their staffs will need to be in the office when the company re-opens its U.S. corporate locations. Amazon (AMZN) is currently expecting employees to come back to the Seattle headquarters, and other locations, starting Jan. 3, 2022.\nThe company--which has more than 1 million employees around the world--was expecting to require all corporate workers to come in to their offices at least three days a week beginning in January. However, Jassy said that having most of its staff working remotely due the Covid-19 pandemic led Amazon to re-evaluate its philosophy about workers needing to be in the office at all times.\n\"At a company of our size, there is no one-size-fits-all approach for how every team works best,\" Jassy said. \"We are intentionally not prescribing how many days or which days [for employees to be in the office]. This is for directors to determine with their senior leaders and teams.\"\nJassy said that he doesn't believe all of Amazon's corporate will be working remotely on a full-time basis.\n\"We expect that there will be teams that continue working mostly remotely, others that will work some combination of remotely and in the office, and still others that will decide customers are best served having the team work mostly in the office,\" Jassy said.\nAmazon (AMZN) had originally intended to re-open its offices in September, but a spike in Covid cases due to the rise of the Delta variant of the virus led it,and many other leading tech companies, to delay their plans until early 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826150646,"gmtCreate":1633998729612,"gmtModify":1633998729844,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[强]&nbsp;","listText":"[强]&nbsp;","text":"[强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/826150646","repostId":"2174893691","repostType":4,"repost":{"id":"2174893691","pubTimestamp":1633998425,"share":"https://www.laohu8.com/m/news/2174893691?lang=&edition=full","pubTime":"2021-10-12 08:27","market":"us","language":"en","title":"Levi’s to Launch Visual Search, Deploy Computer Vision","url":"https://stock-news.laohu8.com/highlight/detail?id=2174893691","media":"WWD","summary":"Levi’s AI drive this year will culminate in new updates that bring computer vision and visual search","content":"<p>Levi’s AI drive this year will culminate in new updates that bring computer vision and visual search technology to the denim brand for the first time. An executive inside the company confirmed to WWD that the announcement will go out sometime this week, in a move teed up for the holiday season.</p>\n<p>The goal, according to Louis DiCesari, global commercial head of data, analytics and artificial intelligence at Levi Strauss &amp; Co., was to boost curation and discovery for shoppers navigating the site, which brims with more than a thousand products. To help, it developed the new Grid Sort feature using a combination of computer vision and neural networks.</p>\n<p>“When you land on a product page, the order is determined by a set of rules that include things like inventory, level and tiering,” DiCesari explained. “We’re furthering that personalization by using real-time information about the user to build a profile on the kinds of products they’re interested in based on what they’ve looked at and purchased in the past. We want to boost up the products that we think the user is interested in.”</p>\n<p>Computer vision allows machines to read and understand images, while neural networks, a form of machine learning or deep learning, takes cues from the structure of the human brain and how biological neurons fire and communicate with each other. Simply put, the latter aims to imbue machines with more human-like ways of thinking and reasoning, allowing them to identify patterns and improve over time.</p>\n<p>“The computer vision allows us to learn from pictures, and better link our family of products and how they relate to each other,” DiCesari continued. “Behind this is a neural network that figures out which products look like other products visually and shows them to the consumer, in the order we predict will be most interesting to them.”</p>\n<p>This sort of image-driven AI application can be more robust than relying on text-based descriptions, which can be hampered by reliance on limited attributes or categorizations. Grid Sort doesn’t have the same limitations, and it’s fast, since it’s updated continuously, nearly in real time.</p>\n<p>The feature just entered testing in the U.S., and the plan is to roll it out globally next year.&nbsp;When it arrives, it will join another feature that will have launched by then: visual search.</p>\n<p>Slated to release in November, visual search allows shoppers to search Levi’s e-commerce site by uploading photos. The tech will pull up results from the store’s assortment that looks similar to the items in the images. Like Grid Sort, it’s also driven by the company’s neural networks.</p>\n<p>Levi’s may be emphasizing computer vision, but that doesn’t mean it’s abandoning text altogether. In fact, as recently as last month it rolled out Personalized <a href=\"https://laohu8.com/S/BPOPM\">Popular</a> Filters, which are clickable text-based filters that live on product pages.</p>\n<p>Like the others, it’s based on what the company knows about its customers.&nbsp;“[Personalized <a href=\"https://laohu8.com/S/BPOPN\">Popular</a> Filters are] different words that narrow down the product mix, depending on what we think the consumer is most interested in,” said DiCesari. “So you might see, like stretchy jeans, or skinny jeans, or 501s, or black jeans, or rib gauge — whatever we predict the consumer is most likely to be interested in. Then the consumer can click that button and see only those products that meet that criterion.”</p>\n<p>New shoppers start out with a standard set of generally popular filters of the moment, “but as we learn about the consumer, we update those filters,” he said. “The algorithm is updated every day, so people who come back to the website will see updated filters based on how they’ve interacted with the website.”</p>\n<p>The latest set of e-commerce updates cap off an intense period for Levi’s AI team, which had to scramble after the upheavals of the pandemic laid to waste its road map for 2020.</p>\n<p>According to a January blog post, “Determining optimal store inventories and predicting store traffic became nearly impossible with stores closed, and the team found themselves with a small problem: With no new data coming in, their data models were about to break.”</p>\n<p>The team jumped into high gear, collaborating cross-regionally to rebuild its predictive models as quickly as possible.&nbsp;Soon after, the company decided to kick off its first AI bootcamp, its bid to cultivate more homegrown talent, as well as teach employees across the organization how to work with data in different ways.</p>\n<p>The efforts seem notable and, for a Bay Area denim brand that has been doing business for more than 160 years, relatively futuristic.</p>\n<p>DiCesari joked that Levi’s was “the original Silicon Valley startup,” which may be an apt description. The company applies AI to various parts of the business, including demand forecasting, marketing and other areas. He called it “a huge focus for us, as a key component of our digital transformation.”</p>\n<p>The newest features have been more than two years in the making, he added, and they may mark a new phase in the company’s AI push in the e-commerce experience. But it’s not limited to shopping, especially when it comes to computer vision.&nbsp;DiCesari wouldn’t disclose precisely what Levi’s is working on next, but he hinted as much.</p>\n<p>“Computer vision can apply to almost every component of what any fashion apparel company does, even down to the design of products,” he said. “So this is an area where the team is definitely dreaming big.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Levi’s to Launch Visual Search, Deploy Computer Vision</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLevi’s to Launch Visual Search, Deploy Computer Vision\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-12 08:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/exclusive-levi-launch-visual-search-233605295.html><strong>WWD</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Levi’s AI drive this year will culminate in new updates that bring computer vision and visual search technology to the denim brand for the first time. An executive inside the company confirmed to WWD ...</p>\n\n<a href=\"https://finance.yahoo.com/news/exclusive-levi-launch-visual-search-233605295.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEVI":"李维斯"},"source_url":"https://finance.yahoo.com/news/exclusive-levi-launch-visual-search-233605295.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2174893691","content_text":"Levi’s AI drive this year will culminate in new updates that bring computer vision and visual search technology to the denim brand for the first time. An executive inside the company confirmed to WWD that the announcement will go out sometime this week, in a move teed up for the holiday season.\nThe goal, according to Louis DiCesari, global commercial head of data, analytics and artificial intelligence at Levi Strauss & Co., was to boost curation and discovery for shoppers navigating the site, which brims with more than a thousand products. To help, it developed the new Grid Sort feature using a combination of computer vision and neural networks.\n“When you land on a product page, the order is determined by a set of rules that include things like inventory, level and tiering,” DiCesari explained. “We’re furthering that personalization by using real-time information about the user to build a profile on the kinds of products they’re interested in based on what they’ve looked at and purchased in the past. We want to boost up the products that we think the user is interested in.”\nComputer vision allows machines to read and understand images, while neural networks, a form of machine learning or deep learning, takes cues from the structure of the human brain and how biological neurons fire and communicate with each other. Simply put, the latter aims to imbue machines with more human-like ways of thinking and reasoning, allowing them to identify patterns and improve over time.\n“The computer vision allows us to learn from pictures, and better link our family of products and how they relate to each other,” DiCesari continued. “Behind this is a neural network that figures out which products look like other products visually and shows them to the consumer, in the order we predict will be most interesting to them.”\nThis sort of image-driven AI application can be more robust than relying on text-based descriptions, which can be hampered by reliance on limited attributes or categorizations. Grid Sort doesn’t have the same limitations, and it’s fast, since it’s updated continuously, nearly in real time.\nThe feature just entered testing in the U.S., and the plan is to roll it out globally next year. When it arrives, it will join another feature that will have launched by then: visual search.\nSlated to release in November, visual search allows shoppers to search Levi’s e-commerce site by uploading photos. The tech will pull up results from the store’s assortment that looks similar to the items in the images. Like Grid Sort, it’s also driven by the company’s neural networks.\nLevi’s may be emphasizing computer vision, but that doesn’t mean it’s abandoning text altogether. In fact, as recently as last month it rolled out Personalized Popular Filters, which are clickable text-based filters that live on product pages.\nLike the others, it’s based on what the company knows about its customers. “[Personalized Popular Filters are] different words that narrow down the product mix, depending on what we think the consumer is most interested in,” said DiCesari. “So you might see, like stretchy jeans, or skinny jeans, or 501s, or black jeans, or rib gauge — whatever we predict the consumer is most likely to be interested in. Then the consumer can click that button and see only those products that meet that criterion.”\nNew shoppers start out with a standard set of generally popular filters of the moment, “but as we learn about the consumer, we update those filters,” he said. “The algorithm is updated every day, so people who come back to the website will see updated filters based on how they’ve interacted with the website.”\nThe latest set of e-commerce updates cap off an intense period for Levi’s AI team, which had to scramble after the upheavals of the pandemic laid to waste its road map for 2020.\nAccording to a January blog post, “Determining optimal store inventories and predicting store traffic became nearly impossible with stores closed, and the team found themselves with a small problem: With no new data coming in, their data models were about to break.”\nThe team jumped into high gear, collaborating cross-regionally to rebuild its predictive models as quickly as possible. Soon after, the company decided to kick off its first AI bootcamp, its bid to cultivate more homegrown talent, as well as teach employees across the organization how to work with data in different ways.\nThe efforts seem notable and, for a Bay Area denim brand that has been doing business for more than 160 years, relatively futuristic.\nDiCesari joked that Levi’s was “the original Silicon Valley startup,” which may be an apt description. The company applies AI to various parts of the business, including demand forecasting, marketing and other areas. He called it “a huge focus for us, as a key component of our digital transformation.”\nThe newest features have been more than two years in the making, he added, and they may mark a new phase in the company’s AI push in the e-commerce experience. But it’s not limited to shopping, especially when it comes to computer vision. DiCesari wouldn’t disclose precisely what Levi’s is working on next, but he hinted as much.\n“Computer vision can apply to almost every component of what any fashion apparel company does, even down to the design of products,” he said. “So this is an area where the team is definitely dreaming big.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":92,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864567473,"gmtCreate":1633133193646,"gmtModify":1633133194324,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;","listText":"[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;","text":"[强] [看涨] [看涨] [梭哈] [美金]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/864567473","repostId":"2172963995","repostType":4,"repost":{"id":"2172963995","pubTimestamp":1633102399,"share":"https://www.laohu8.com/m/news/2172963995?lang=&edition=full","pubTime":"2021-10-01 23:33","market":"us","language":"en","title":"Here's Why Smart Investors Are Watching Pinterest Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2172963995","media":"Motley Fool","summary":"The market is turning sour on this image-based, social media business -- which could be an opportunity.","content":"<p>Savvy investors tend to have an uncanny ability to find good values. So it will not be surprising if there is an increasing share of sharp investors paying attention to <b>Pinterest</b> (NYSE:PINS) stock right now.</p>\n<p>The image-based, social-media app benefited tremendously at the pandemic's onset and is now experiencing a reversal of that trend. The company's shares are down 36% in the past three months and 24% in 2021. The fall could create an opportunity for long-term investors.</p>\n<p><img src=\"https://static.tigerbbs.com/4f46510b15abbc1b81f12e02789488a8\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>Pinterest sheds monthly active users</h2>\n<p>The primary cause of Pinterest stock's decrease is a drop in monthly active users from the previous quarter. The market was expecting an increase. In its fiscal second quarter ended June 30, Pinterest reported a drop of 24 million users from the previous quarter -- down to a total of 454 million monthly active users. These are folks around the world who spend time browsing the app. Advertisers are interested in gaining their attention and are willing to pay Pinterest for the privilege to do so. Fewer users mean advertisers pay less to Pinterest.</p>\n<p>The surprising turnaround in the trend makes investors unsure if the loss in Pinterest users was a <a href=\"https://laohu8.com/S/AONE.U\">one</a>-quarter event or if it will continue downward. As is usual with any business, uncertainty adds risk; and all else being equal, investors want less risk.</p>\n<h2>Not as damaging as it looks</h2>\n<p>But Pinterest's loss of monthly active users in the quarter is not as bad as it looks on the surface. After spending so much time cooped up at home, it's understandable that folks are going out more often as economies reopen. Therein lies an upside to reopening economies: Businesses are ramping up advertising to get the word out that they are open. That boost in ad&nbsp; sales increased Pinterest's revenue by 125% in the second quarter vs. the same time last year.</p>\n<p>Moreover, even though the numbers show a decline in monthly active users, it doesn't necessarily mean Pinterest has lost those consumers permanently; it just means they haven't opened their app or logged in from a computer browser in the past month. It is very possible that some of those users will reconnect after spending some time away.</p>\n<h2>Pinterest stock is trading at a lower price</h2>\n<p>Nevertheless, the market turned sour on the stock, and it has continued to fall. Pinterest is trading at a price-to-sales ratio of 14, down significantly from the 32 it was selling for earlier in the year. Using that metric, the stock is still not cheap, trading right around its historical average.</p>\n<p>That could be why intelligent investors are not buying the stock in large quantities just yet. Pinterest is likely on their watch lists, and they are waiting for the stock to either fall further or for better news regarding monthly active users. Even if Pinterest reports that monthly active user growth is leveling off, it could entice the market to change its sentiment as the risk diminishes -- and to intelligent investors, reducing risk is adding value.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Smart Investors Are Watching Pinterest Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Smart Investors Are Watching Pinterest Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 23:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/01/pinterest-is-a-growth-stock-investors-are-watching/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Savvy investors tend to have an uncanny ability to find good values. So it will not be surprising if there is an increasing share of sharp investors paying attention to Pinterest (NYSE:PINS) stock ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/01/pinterest-is-a-growth-stock-investors-are-watching/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISBC":"投资者银行"},"source_url":"https://www.fool.com/investing/2021/10/01/pinterest-is-a-growth-stock-investors-are-watching/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172963995","content_text":"Savvy investors tend to have an uncanny ability to find good values. So it will not be surprising if there is an increasing share of sharp investors paying attention to Pinterest (NYSE:PINS) stock right now.\nThe image-based, social-media app benefited tremendously at the pandemic's onset and is now experiencing a reversal of that trend. The company's shares are down 36% in the past three months and 24% in 2021. The fall could create an opportunity for long-term investors.\n\nImage source: Getty Images.\nPinterest sheds monthly active users\nThe primary cause of Pinterest stock's decrease is a drop in monthly active users from the previous quarter. The market was expecting an increase. In its fiscal second quarter ended June 30, Pinterest reported a drop of 24 million users from the previous quarter -- down to a total of 454 million monthly active users. These are folks around the world who spend time browsing the app. Advertisers are interested in gaining their attention and are willing to pay Pinterest for the privilege to do so. Fewer users mean advertisers pay less to Pinterest.\nThe surprising turnaround in the trend makes investors unsure if the loss in Pinterest users was a one-quarter event or if it will continue downward. As is usual with any business, uncertainty adds risk; and all else being equal, investors want less risk.\nNot as damaging as it looks\nBut Pinterest's loss of monthly active users in the quarter is not as bad as it looks on the surface. After spending so much time cooped up at home, it's understandable that folks are going out more often as economies reopen. Therein lies an upside to reopening economies: Businesses are ramping up advertising to get the word out that they are open. That boost in ad  sales increased Pinterest's revenue by 125% in the second quarter vs. the same time last year.\nMoreover, even though the numbers show a decline in monthly active users, it doesn't necessarily mean Pinterest has lost those consumers permanently; it just means they haven't opened their app or logged in from a computer browser in the past month. It is very possible that some of those users will reconnect after spending some time away.\nPinterest stock is trading at a lower price\nNevertheless, the market turned sour on the stock, and it has continued to fall. Pinterest is trading at a price-to-sales ratio of 14, down significantly from the 32 it was selling for earlier in the year. Using that metric, the stock is still not cheap, trading right around its historical average.\nThat could be why intelligent investors are not buying the stock in large quantities just yet. Pinterest is likely on their watch lists, and they are waiting for the stock to either fall further or for better news regarding monthly active users. Even if Pinterest reports that monthly active user growth is leveling off, it could entice the market to change its sentiment as the risk diminishes -- and to intelligent investors, reducing risk is adding value.","news_type":1},"isVote":1,"tweetType":1,"viewCount":25,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":869075249,"gmtCreate":1632232487581,"gmtModify":1632801904947,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[财迷]&nbsp;[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"[财迷]&nbsp;[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"[财迷] [强] [看涨] [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/869075249","repostId":"1165739145","repostType":4,"repost":{"id":"1165739145","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632231054,"share":"https://www.laohu8.com/m/news/1165739145?lang=&edition=full","pubTime":"2021-09-21 21:30","market":"us","language":"en","title":"U.S. stocks gain at Tuesday's open","url":"https://stock-news.laohu8.com/highlight/detail?id=1165739145","media":"Tiger Newspress","summary":"(Sept 21) U.S. stocks gain at Tuesday's open. Dow Jones, S&P and Nasdaq start higher following yeste","content":"<p>(Sept 21)&nbsp;U.S. stocks gain at Tuesday's open.&nbsp;Dow Jones, S&amp;P and Nasdaq start higher following yesterday's selloff.</p>\n<p>Uber shares jumped 7%&nbsp;after raising its outlook&nbsp;for the third quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/76c76d195eaa24d0309a2ef2686f857c\" tg-width=\"1110\" tg-height=\"570\" width=\"100%\" height=\"auto\"></p>\n<p>Luckin Coffee surged&nbsp;17%&nbsp;in&nbsp;early&nbsp;trading&nbsp;after&nbsp;it&nbsp;Files Annual Report for Fiscal 2020,&nbsp;it's&nbsp;FY Revenue of $618.1M, representing an increase of 33.3% compared to 2019.</p>\n<p><img src=\"https://static.tigerbbs.com/a3ab3b5d35e96e056850f7b1739d7a86\" tg-width=\"1111\" tg-height=\"568\" referrerpolicy=\"no-referrer\"></p>\n<p>QuantumScape soars nearly&nbsp;10%&nbsp;after another deal with 'top ten' automaker.</p>\n<p><img src=\"https://static.tigerbbs.com/19b0517a9824a37a70b8f1d10c5f2fd9\" tg-width=\"1111\" tg-height=\"566\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stocks gain at Tuesday's open</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stocks gain at Tuesday's open\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-21 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 21)&nbsp;U.S. stocks gain at Tuesday's open.&nbsp;Dow Jones, S&amp;P and Nasdaq start higher following yesterday's selloff.</p>\n<p>Uber shares jumped 7%&nbsp;after raising its outlook&nbsp;for the third quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/76c76d195eaa24d0309a2ef2686f857c\" tg-width=\"1110\" tg-height=\"570\" width=\"100%\" height=\"auto\"></p>\n<p>Luckin Coffee surged&nbsp;17%&nbsp;in&nbsp;early&nbsp;trading&nbsp;after&nbsp;it&nbsp;Files Annual Report for Fiscal 2020,&nbsp;it's&nbsp;FY Revenue of $618.1M, representing an increase of 33.3% compared to 2019.</p>\n<p><img src=\"https://static.tigerbbs.com/a3ab3b5d35e96e056850f7b1739d7a86\" tg-width=\"1111\" tg-height=\"568\" referrerpolicy=\"no-referrer\"></p>\n<p>QuantumScape soars nearly&nbsp;10%&nbsp;after another deal with 'top ten' automaker.</p>\n<p><img src=\"https://static.tigerbbs.com/19b0517a9824a37a70b8f1d10c5f2fd9\" tg-width=\"1111\" tg-height=\"566\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165739145","content_text":"(Sept 21) U.S. stocks gain at Tuesday's open. Dow Jones, S&P and Nasdaq start higher following yesterday's selloff.\nUber shares jumped 7% after raising its outlook for the third quarter.\n\nLuckin Coffee surged 17% in early trading after it Files Annual Report for Fiscal 2020, it's FY Revenue of $618.1M, representing an increase of 33.3% compared to 2019.\n\nQuantumScape soars nearly 10% after another deal with 'top ten' automaker.","news_type":1},"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":817481709,"gmtCreate":1630980475501,"gmtModify":1631891950408,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Can I buy AT&amp;T? Is it the time to go in?[财迷]&nbsp;[得意]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;","listText":"Can I buy AT&amp;T? Is it the time to go in?[财迷]&nbsp;[得意]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[梭哈]&nbsp;[美金]&nbsp;","text":"Can I buy AT&T? Is it the time to go in?[财迷] [得意] [看涨] [看涨] [梭哈] [美金]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/817481709","repostId":"2165387793","repostType":4,"repost":{"id":"2165387793","pubTimestamp":1630979834,"share":"https://www.laohu8.com/m/news/2165387793?lang=&edition=full","pubTime":"2021-09-07 09:57","market":"us","language":"en","title":"Has AT&T Stock Gotten Too Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2165387793","media":"Motley Fool","summary":"AT&T is going back to its telecom roots, and that might be good news for investors.","content":"<p>Telecom company <b>AT&amp;T</b> (NYSE:T) recently ended its journey into digital content, which began in 2015 when it bought DIRECTV for $49 billion, and later bought Time Warner for another $85 billion in 2018. Investors never liked the progress AT&amp;T made with video; the stock is down more than 30% over the past five years.</p>\n<p>AT&amp;T is now spinning off its Warner Media business, combining with <b>Discovery</b> to form a stand-alone company. This makes AT&amp;T a dedicated telecom business again, but here are three reasons investors should be excited about that.</p>\n<h2>1. Turning <a href=\"https://laohu8.com/S/AONE.U\">one</a> stock into two</h2>\n<p>Just because AT&amp;T is getting out of streaming and content doesn't mean that its shareholders need to. As a part of the merger between Warner Media and Discovery, AT&amp;T's shareholders will receive 71% of the resulting equity. In other words, if you own AT&amp;T stock, you will be receiving shares of the new company.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F641248%2Fgettyimages-1217003014.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>The new company will have all of AT&amp;T's media assets, including HBO and HBO Max, Warner Bros., DC Universe, TBS, TNT, CNN, Cartoon Network, and many more brands and channels, which will be combined with Discovery's own channel lineup, including Discovery, HGTV, Food Network, TLC, and more.</p>\n<p>The new company, called Warner Bros. Discovery, will clearly have a massive collection of intellectual property, as well as a streaming service to distribute it. Warner Media will bring HBO Max, and Discovery also owns a service it calls Discovery Plus.</p>\n<p>The new company will obviously need to prove itself, but AT&amp;T investors are now receiving an ownership stake in this new business in addition to their existing ownership of AT&amp;T's telecom business.</p>\n<h2>2. Healing the balance sheet</h2>\n<p>AT&amp;T's huge debt load has been one of the primary reasons the stock price has languished over the years. The company borrowed heavily to fund the acquisitions of DIRECTV and Time Warner and never made meaningful progress in paying down the balance sheet since the Time Warner deal three years ago.</p>\n<p>The company currently has roughly $180 billion of total debt on its balance sheet and is leveraged to a debt-to-EBITDA ratio of four, meaning AT&amp;T has four times as much debt as it does earnings before interest, taxes, depreciation, and amortization (earnings before a bunch of accounting adjustments).</p>\n<p>AT&amp;T's debt/EBITDA ratio was roughly two before buying DIRECTV, so the company has taken on a lot of debt over the past five years. As part of the Discovery deal, AT&amp;T is offloading $43 billion in debt, which will bring the company's debt/EBITDA to about 2.6 when the deal closes in mid-2022, and management plans to further pay down debt from there.</p>\n<p>Management did slip in a dividend cut, guiding a dividend payout ratio equal to 40% of AT&amp;T's anticipated $20 billion in cash flow following the spinoff. This would mean about $8 billion is allocated to the dividend when the company spent $15 billion on dividends in 2020. The rough math points to a 50% cut, which will probably irritate dividend investors.</p>\n<p>However, it's important to remember that investors are currently enjoying a 7.6% dividend yield, so the reduced dividend will still pay more than many other dividend stocks. The company could use the extra cash to buy back shares, which would help its earnings per share and help push the stock price higher.</p>\n<h2>3. AT&amp;T is too cheap</h2>\n<p>AT&amp;T is expected to earn $3.36 per share in 2021, so the stock trades at a price-to-earnings ratio of 8.1, significantly less than the <b>S&amp;P 500</b>'s forward P/E ratio of 22. When the spinoff happens, AT&amp;T will see its earnings fall; the Warner Media business brought in roughly one-fifth of AT&amp;T's profits in 2020.</p>\n<p>However, remember that investors will receive this in the form of shares in the new Warner Bros. Discovery company. AT&amp;T would still be trading at a steep discount to the market without the contributions of Warner Media, so the stock appears very attractively priced before considering the bonus of shares from the spinoff.</p>\n<h2>A bargain in the making</h2>\n<p>In AT&amp;T, investors will be left with a more focused telecom business that is carrying less debt, and would have the financial flexibility for stock buybacks or to further pay down its debt. It's very possible that investors could award the stock with a higher valuation as the company's balance sheet improves, making AT&amp;T seem like a bargain at today's price.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Has AT&T Stock Gotten Too Cheap?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHas AT&T Stock Gotten Too Cheap?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 09:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/06/has-att-stock-gotten-too-cheap/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Telecom company AT&T (NYSE:T) recently ended its journey into digital content, which began in 2015 when it bought DIRECTV for $49 billion, and later bought Time Warner for another $85 billion in 2018....</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/06/has-att-stock-gotten-too-cheap/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"T":"美国电话电报"},"source_url":"https://www.fool.com/investing/2021/09/06/has-att-stock-gotten-too-cheap/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165387793","content_text":"Telecom company AT&T (NYSE:T) recently ended its journey into digital content, which began in 2015 when it bought DIRECTV for $49 billion, and later bought Time Warner for another $85 billion in 2018. Investors never liked the progress AT&T made with video; the stock is down more than 30% over the past five years.\nAT&T is now spinning off its Warner Media business, combining with Discovery to form a stand-alone company. This makes AT&T a dedicated telecom business again, but here are three reasons investors should be excited about that.\n1. Turning one stock into two\nJust because AT&T is getting out of streaming and content doesn't mean that its shareholders need to. As a part of the merger between Warner Media and Discovery, AT&T's shareholders will receive 71% of the resulting equity. In other words, if you own AT&T stock, you will be receiving shares of the new company.\nImage source: Getty Images.\nThe new company will have all of AT&T's media assets, including HBO and HBO Max, Warner Bros., DC Universe, TBS, TNT, CNN, Cartoon Network, and many more brands and channels, which will be combined with Discovery's own channel lineup, including Discovery, HGTV, Food Network, TLC, and more.\nThe new company, called Warner Bros. Discovery, will clearly have a massive collection of intellectual property, as well as a streaming service to distribute it. Warner Media will bring HBO Max, and Discovery also owns a service it calls Discovery Plus.\nThe new company will obviously need to prove itself, but AT&T investors are now receiving an ownership stake in this new business in addition to their existing ownership of AT&T's telecom business.\n2. Healing the balance sheet\nAT&T's huge debt load has been one of the primary reasons the stock price has languished over the years. The company borrowed heavily to fund the acquisitions of DIRECTV and Time Warner and never made meaningful progress in paying down the balance sheet since the Time Warner deal three years ago.\nThe company currently has roughly $180 billion of total debt on its balance sheet and is leveraged to a debt-to-EBITDA ratio of four, meaning AT&T has four times as much debt as it does earnings before interest, taxes, depreciation, and amortization (earnings before a bunch of accounting adjustments).\nAT&T's debt/EBITDA ratio was roughly two before buying DIRECTV, so the company has taken on a lot of debt over the past five years. As part of the Discovery deal, AT&T is offloading $43 billion in debt, which will bring the company's debt/EBITDA to about 2.6 when the deal closes in mid-2022, and management plans to further pay down debt from there.\nManagement did slip in a dividend cut, guiding a dividend payout ratio equal to 40% of AT&T's anticipated $20 billion in cash flow following the spinoff. This would mean about $8 billion is allocated to the dividend when the company spent $15 billion on dividends in 2020. The rough math points to a 50% cut, which will probably irritate dividend investors.\nHowever, it's important to remember that investors are currently enjoying a 7.6% dividend yield, so the reduced dividend will still pay more than many other dividend stocks. The company could use the extra cash to buy back shares, which would help its earnings per share and help push the stock price higher.\n3. AT&T is too cheap\nAT&T is expected to earn $3.36 per share in 2021, so the stock trades at a price-to-earnings ratio of 8.1, significantly less than the S&P 500's forward P/E ratio of 22. When the spinoff happens, AT&T will see its earnings fall; the Warner Media business brought in roughly one-fifth of AT&T's profits in 2020.\nHowever, remember that investors will receive this in the form of shares in the new Warner Bros. Discovery company. AT&T would still be trading at a steep discount to the market without the contributions of Warner Media, so the stock appears very attractively priced before considering the bonus of shares from the spinoff.\nA bargain in the making\nIn AT&T, investors will be left with a more focused telecom business that is carrying less debt, and would have the financial flexibility for stock buybacks or to further pay down its debt. It's very possible that investors could award the stock with a higher valuation as the company's balance sheet improves, making AT&T seem like a bargain at today's price.","news_type":1},"isVote":1,"tweetType":1,"viewCount":28,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":811182470,"gmtCreate":1630297743490,"gmtModify":1704958024830,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[财迷]&nbsp;[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[美金]&nbsp;[梭哈]&nbsp;","listText":"[财迷]&nbsp;[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[美金]&nbsp;[梭哈]&nbsp;","text":"[财迷] [强] [看涨] [看涨] [看涨] [美金] [梭哈]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/811182470","repostId":"1129600310","repostType":4,"isVote":1,"tweetType":1,"viewCount":20,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":173799104,"gmtCreate":1626684624408,"gmtModify":1633924951724,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Wow didn't get my bullet ready yet[流泪]&nbsp;[捂脸]&nbsp;","listText":"Wow didn't get my bullet ready yet[流泪]&nbsp;[捂脸]&nbsp;","text":"Wow didn't get my bullet ready yet[流泪] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/173799104","repostId":"1156640437","repostType":4,"repost":{"id":"1156640437","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626682348,"share":"https://www.laohu8.com/m/news/1156640437?lang=&edition=full","pubTime":"2021-07-19 16:12","market":"us","language":"en","title":"Five9 rose more than 10% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1156640437","media":"Tiger Newspress","summary":"(July 19) Five9 rose more than 10% in premarket trading. Zoom to buy cloud sTiger Newspressoftware p","content":"<p>(July&nbsp;19)&nbsp;<a href=\"https://laohu8.com/S/FIVN\">Five9</a> rose more than 10% in premarket trading.&nbsp;<a href=\"https://laohu8.com/S/ZM\">Zoom</a> to buy cloud sTiger Newspressoftware provider Five9 in $15 billion deal.</p>\n<p><img src=\"https://static.tigerbbs.com/a2ef4a37f41134967f511878510c38e9\" tg-width=\"642\" tg-height=\"460\" referrerpolicy=\"no-referrer\">Teleconferencing services provider <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video <a href=\"https://laohu8.com/S/JCS\">Communications</a> Inc has struck a deal to buy cloud software provider <a href=\"https://laohu8.com/S/FIVN\">Five9 Inc</a> in an all-stock transaction valued at about $14.7 billion, the company said on Sunday.</p>\n<p>Five9 will become an operating unit of Zoom and its chief executive, Rowan Trollope, will become a president of Zoom and stay on as chief of the unit after the deal, which is expected to close in the first half of 2022, it said in a statement.</p>\n<p>Under the pact, approved by the boards of both companies, Five9 stockholders will receive 0.5533 shares of Class A common stock of Zoom for each share of Five9, it added.</p>\n<p>Based on the July 16 closing share price of Zoom Class A common stock, this represents a price of $200.28 for each share of Five9 common stock, and an implied deal value of about $14.7 billion.</p>\n<p>Zoom has become a household name and investor favorite in the year since the coronavirus pandemic, as businesses and schools adopted its services to hold virtual classes, office meets and socialise.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Five9 rose more than 10% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFive9 rose more than 10% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-19 16:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July&nbsp;19)&nbsp;<a href=\"https://laohu8.com/S/FIVN\">Five9</a> rose more than 10% in premarket trading.&nbsp;<a href=\"https://laohu8.com/S/ZM\">Zoom</a> to buy cloud sTiger Newspressoftware provider Five9 in $15 billion deal.</p>\n<p><img src=\"https://static.tigerbbs.com/a2ef4a37f41134967f511878510c38e9\" tg-width=\"642\" tg-height=\"460\" referrerpolicy=\"no-referrer\">Teleconferencing services provider <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video <a href=\"https://laohu8.com/S/JCS\">Communications</a> Inc has struck a deal to buy cloud software provider <a href=\"https://laohu8.com/S/FIVN\">Five9 Inc</a> in an all-stock transaction valued at about $14.7 billion, the company said on Sunday.</p>\n<p>Five9 will become an operating unit of Zoom and its chief executive, Rowan Trollope, will become a president of Zoom and stay on as chief of the unit after the deal, which is expected to close in the first half of 2022, it said in a statement.</p>\n<p>Under the pact, approved by the boards of both companies, Five9 stockholders will receive 0.5533 shares of Class A common stock of Zoom for each share of Five9, it added.</p>\n<p>Based on the July 16 closing share price of Zoom Class A common stock, this represents a price of $200.28 for each share of Five9 common stock, and an implied deal value of about $14.7 billion.</p>\n<p>Zoom has become a household name and investor favorite in the year since the coronavirus pandemic, as businesses and schools adopted its services to hold virtual classes, office meets and socialise.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FIVN":"Five9 Inc","ZM":"Zoom"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156640437","content_text":"(July 19) Five9 rose more than 10% in premarket trading. Zoom to buy cloud sTiger Newspressoftware provider Five9 in $15 billion deal.\nTeleconferencing services provider Zoom Video Communications Inc has struck a deal to buy cloud software provider Five9 Inc in an all-stock transaction valued at about $14.7 billion, the company said on Sunday.\nFive9 will become an operating unit of Zoom and its chief executive, Rowan Trollope, will become a president of Zoom and stay on as chief of the unit after the deal, which is expected to close in the first half of 2022, it said in a statement.\nUnder the pact, approved by the boards of both companies, Five9 stockholders will receive 0.5533 shares of Class A common stock of Zoom for each share of Five9, it added.\nBased on the July 16 closing share price of Zoom Class A common stock, this represents a price of $200.28 for each share of Five9 common stock, and an implied deal value of about $14.7 billion.\nZoom has become a household name and investor favorite in the year since the coronavirus pandemic, as businesses and schools adopted its services to hold virtual classes, office meets and socialise.","news_type":1},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862316070,"gmtCreate":1632837329388,"gmtModify":1632837329616,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Is there any Pharmaceutical ETF to recommend?[梭哈]&nbsp;[美金]&nbsp;","listText":"Is there any Pharmaceutical ETF to recommend?[梭哈]&nbsp;[美金]&nbsp;","text":"Is there any Pharmaceutical ETF to recommend?[梭哈] [美金]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862316070","repostId":"1193693996","repostType":4,"repost":{"id":"1193693996","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632836938,"share":"https://www.laohu8.com/m/news/1193693996?lang=&edition=full","pubTime":"2021-09-28 21:48","market":"us","language":"en","title":"Pharmaceutical stocks slid in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693996","media":"Tiger Newspress","summary":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca f","content":"<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks slid in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks slid in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-28 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna&nbsp;and&nbsp;AstraZeneca&nbsp;fell&nbsp;between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","AZN":"阿斯利康","LLY":"礼来","GILD":"吉利德科学","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","REGN":"再生元制药公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193693996","content_text":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca fell between 1% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":816729512,"gmtCreate":1630537230036,"gmtModify":1631891950438,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Up up up[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[美金]&nbsp;","listText":"Up up up[强]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[美金]&nbsp;","text":"Up up up[强] [看涨] [看涨] [看涨] [美金]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/816729512","repostId":"2164481914","repostType":4,"repost":{"id":"2164481914","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630529217,"share":"https://www.laohu8.com/m/news/2164481914?lang=&edition=full","pubTime":"2021-09-02 04:46","market":"us","language":"en","title":"Tech stocks send Nasdaq to fresh record close, boost S&P","url":"https://stock-news.laohu8.com/highlight/detail?id=2164481914","media":"Reuters","summary":"Gains for tech stocks, utilities and real estate.\nAugust private jobs growth misses expectations.\nIn","content":"<ul>\n <li>Gains for tech stocks, utilities and real estate.</li>\n <li>August private jobs growth misses expectations.</li>\n <li>Indexes: Dow falls 0.14%, S&amp;P up 0.03%, Nasdaq rises 0.33%.</li>\n</ul>\n<p>Sept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&amp;P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.</p>\n<p>Technology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.</p>\n<p>Utilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.</p>\n<p>\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.</p>\n<p>Wall Street's main indexes have hit record highs recently, with the benchmark S&amp;P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.</p>\n<p>Each new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.</p>\n<p>A report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.</p>\n<p>Another set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.</p>\n<p>\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.</p>\n<p>The Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&amp;P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.</p>\n<p>Falling 1.5% on the day, and down for the third straight session, was the energy index.</p>\n<p>Crude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established&nbsp;More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.</p>\n<p><a href=\"https://laohu8.com/S/PBF\">PBF Energy</a> Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.</p>\n<p>Volume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.</p>\n<p>The S&amp;P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech stocks send Nasdaq to fresh record close, boost S&P</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech stocks send Nasdaq to fresh record close, boost S&P\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-02 04:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Gains for tech stocks, utilities and real estate.</li>\n <li>August private jobs growth misses expectations.</li>\n <li>Indexes: Dow falls 0.14%, S&amp;P up 0.03%, Nasdaq rises 0.33%.</li>\n</ul>\n<p>Sept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&amp;P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.</p>\n<p>Technology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.</p>\n<p>Utilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.</p>\n<p>\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.</p>\n<p>Wall Street's main indexes have hit record highs recently, with the benchmark S&amp;P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.</p>\n<p>Each new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.</p>\n<p>A report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.</p>\n<p>Another set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.</p>\n<p>\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.</p>\n<p>The Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&amp;P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.</p>\n<p>Falling 1.5% on the day, and down for the third straight session, was the energy index.</p>\n<p>Crude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established&nbsp;More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.</p>\n<p><a href=\"https://laohu8.com/S/PBF\">PBF Energy</a> Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.</p>\n<p>Volume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.</p>\n<p>The S&amp;P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164481914","content_text":"Gains for tech stocks, utilities and real estate.\nAugust private jobs growth misses expectations.\nIndexes: Dow falls 0.14%, S&P up 0.03%, Nasdaq rises 0.33%.\n\nSept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.\nTechnology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and Facebook Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.\nUtilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.\n\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.\nWall Street's main indexes have hit record highs recently, with the benchmark S&P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.\nEach new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.\nA report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.\nAnother set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.\n\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.\nThe Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.\nFalling 1.5% on the day, and down for the third straight session, was the energy index.\nCrude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.\nPBF Energy Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.\nVolume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.\nThe S&P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.\n(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":801077781,"gmtCreate":1627477367943,"gmtModify":1633764654575,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Good buy . Must buy[吃瓜]&nbsp;[哇塞]&nbsp;","listText":"Good buy . Must buy[吃瓜]&nbsp;[哇塞]&nbsp;","text":"Good buy . Must buy[吃瓜] [哇塞]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801077781","repostId":"2154929448","repostType":4,"repost":{"id":"2154929448","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627476589,"share":"https://www.laohu8.com/m/news/2154929448?lang=&edition=full","pubTime":"2021-07-28 20:49","market":"us","language":"en","title":"Apple, AMD navigate chip shortage with focus on profitable products","url":"https://stock-news.laohu8.com/highlight/detail?id=2154929448","media":"Reuters","summary":"The global chip shortage has grounded major automotive factories to a halt but pushed technology gia","content":"<p>The global chip shortage has grounded major automotive factories to a halt but pushed technology giants to become more flexible by diverting existing supplies to their most profitable products, analysts and executives said.</p>\n<p>Apple Inc said on Tuesday chip shortages had mostly affected its iPad and Mac products in its last quarter, but would start to bite into its mainstay iPhone business, its best seller and major profit driver, in the current quarter.</p>\n<p>\"We'll do everything we can to mitigate whatever set of circumstances we're dealt,\" Chief Executive Officer Tim Cook said in a post earnings conference call.</p>\n<p>The comments provide an insight into how Apple, known for its deft supply chain management through long-term supply deals with Broadcom Inc and Qualcomm Inc, is dealing with the shortage ahead of the crucial holiday quarter when it sells millions of its new line of flagship phones.</p>\n<p>Some analysts believe Apple could be prioritizing chip supplies for its new phones during the July-September quarter, which is typically the sleepiest for iPhone sales as shoppers hold out for upcoming models.</p>\n<p>\"I think it largely reflects the timing of new product releases, specifically related to new iPhone launches in September,\" Angelo Zino, an analyst with research firm CFRA, said of Apple's warning.</p>\n<p>Even in normal times, he said, \"new phone cycles typically start off supply constrained given the high demand needs ahead of the holiday selling season.\"</p>\n<p>And even within Apple's current lineup, the company is likely to direct the supply chain pain to its least lucrative products, said Jeff Fieldhack, research director at Counterpoint Research.</p>\n<p>Its flagship phones also drive revenue from paid subscription services and accessories like AirPods.</p>\n<p>\"Assuming Apple prioritizes the iPhone 12 family, it probably affects iPads, Macs and older iPhones more,\" Fieldhack said.</p>\n<p>The global chip shortage stems from a combination of factors including the fallout from last year's COVID-19 shutdowns and factories struggling to meet demand for semiconductors, which have become omnipresent in an increasingly digitized world.</p>\n<p>The supply squeeze took the auto industry by surprise. Car makers like Ford Motor Co and General Motors Co had to halt production lines for their popular pick-ups at a time when demand was booming as economies started to open up.</p>\n<p>The auto industry relies almost exclusively on chips from a few manufacturers, so-called foundries, including Taiwan Semiconductor Manufacturing Co (TSMC) and South Korea's Samsung Electronics Co Ltd. The shortage has exposed this reliance on overseas suppliers as an Achilles' heel for many companies.</p>\n<p><b>STRATEGIC FOCUS</b></p>\n<p>Technology companies, the traditional consumers of semiconductors, have been more nimble.</p>\n<p>Chip designer Advanced Micro Devices, which makes central processor chips for PCs and data center servers, has also been redirecting supplies.</p>\n<p>The company, which has a new family of chips that outperform offerings from larger rival Intel Corp, has steadily made gains in unit sales market share against the chip giant, which retains more than 80% of the overall market.</p>\n<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> has responded to limited industry capacity by focusing on selling only its most profitable chips, leaving the lower end of the market to Intel, said Dean McCarron of Mercury Research, which tracks market share among chipmakers.</p>\n<p>Intel has also been struggling with its own set of challenges with manufacturing in recent years, causing it to fall behind AMD and Nvidia Corp.</p>\n<p>\"We're focusing on the most strategic segments of the PC market,\" AMD CEO Lisa Su told investors on a conference call.</p>\n<p>\"We believe that the data center business will continue to be a strong driver for us into the second half of the year.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple, AMD navigate chip shortage with focus on profitable products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple, AMD navigate chip shortage with focus on profitable products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-28 20:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The global chip shortage has grounded major automotive factories to a halt but pushed technology giants to become more flexible by diverting existing supplies to their most profitable products, analysts and executives said.</p>\n<p>Apple Inc said on Tuesday chip shortages had mostly affected its iPad and Mac products in its last quarter, but would start to bite into its mainstay iPhone business, its best seller and major profit driver, in the current quarter.</p>\n<p>\"We'll do everything we can to mitigate whatever set of circumstances we're dealt,\" Chief Executive Officer Tim Cook said in a post earnings conference call.</p>\n<p>The comments provide an insight into how Apple, known for its deft supply chain management through long-term supply deals with Broadcom Inc and Qualcomm Inc, is dealing with the shortage ahead of the crucial holiday quarter when it sells millions of its new line of flagship phones.</p>\n<p>Some analysts believe Apple could be prioritizing chip supplies for its new phones during the July-September quarter, which is typically the sleepiest for iPhone sales as shoppers hold out for upcoming models.</p>\n<p>\"I think it largely reflects the timing of new product releases, specifically related to new iPhone launches in September,\" Angelo Zino, an analyst with research firm CFRA, said of Apple's warning.</p>\n<p>Even in normal times, he said, \"new phone cycles typically start off supply constrained given the high demand needs ahead of the holiday selling season.\"</p>\n<p>And even within Apple's current lineup, the company is likely to direct the supply chain pain to its least lucrative products, said Jeff Fieldhack, research director at Counterpoint Research.</p>\n<p>Its flagship phones also drive revenue from paid subscription services and accessories like AirPods.</p>\n<p>\"Assuming Apple prioritizes the iPhone 12 family, it probably affects iPads, Macs and older iPhones more,\" Fieldhack said.</p>\n<p>The global chip shortage stems from a combination of factors including the fallout from last year's COVID-19 shutdowns and factories struggling to meet demand for semiconductors, which have become omnipresent in an increasingly digitized world.</p>\n<p>The supply squeeze took the auto industry by surprise. Car makers like Ford Motor Co and General Motors Co had to halt production lines for their popular pick-ups at a time when demand was booming as economies started to open up.</p>\n<p>The auto industry relies almost exclusively on chips from a few manufacturers, so-called foundries, including Taiwan Semiconductor Manufacturing Co (TSMC) and South Korea's Samsung Electronics Co Ltd. The shortage has exposed this reliance on overseas suppliers as an Achilles' heel for many companies.</p>\n<p><b>STRATEGIC FOCUS</b></p>\n<p>Technology companies, the traditional consumers of semiconductors, have been more nimble.</p>\n<p>Chip designer Advanced Micro Devices, which makes central processor chips for PCs and data center servers, has also been redirecting supplies.</p>\n<p>The company, which has a new family of chips that outperform offerings from larger rival Intel Corp, has steadily made gains in unit sales market share against the chip giant, which retains more than 80% of the overall market.</p>\n<p><a href=\"https://laohu8.com/S/AMD\">AMD</a> has responded to limited industry capacity by focusing on selling only its most profitable chips, leaving the lower end of the market to Intel, said Dean McCarron of Mercury Research, which tracks market share among chipmakers.</p>\n<p>Intel has also been struggling with its own set of challenges with manufacturing in recent years, causing it to fall behind AMD and Nvidia Corp.</p>\n<p>\"We're focusing on the most strategic segments of the PC market,\" AMD CEO Lisa Su told investors on a conference call.</p>\n<p>\"We believe that the data center business will continue to be a strong driver for us into the second half of the year.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2154929448","content_text":"The global chip shortage has grounded major automotive factories to a halt but pushed technology giants to become more flexible by diverting existing supplies to their most profitable products, analysts and executives said.\nApple Inc said on Tuesday chip shortages had mostly affected its iPad and Mac products in its last quarter, but would start to bite into its mainstay iPhone business, its best seller and major profit driver, in the current quarter.\n\"We'll do everything we can to mitigate whatever set of circumstances we're dealt,\" Chief Executive Officer Tim Cook said in a post earnings conference call.\nThe comments provide an insight into how Apple, known for its deft supply chain management through long-term supply deals with Broadcom Inc and Qualcomm Inc, is dealing with the shortage ahead of the crucial holiday quarter when it sells millions of its new line of flagship phones.\nSome analysts believe Apple could be prioritizing chip supplies for its new phones during the July-September quarter, which is typically the sleepiest for iPhone sales as shoppers hold out for upcoming models.\n\"I think it largely reflects the timing of new product releases, specifically related to new iPhone launches in September,\" Angelo Zino, an analyst with research firm CFRA, said of Apple's warning.\nEven in normal times, he said, \"new phone cycles typically start off supply constrained given the high demand needs ahead of the holiday selling season.\"\nAnd even within Apple's current lineup, the company is likely to direct the supply chain pain to its least lucrative products, said Jeff Fieldhack, research director at Counterpoint Research.\nIts flagship phones also drive revenue from paid subscription services and accessories like AirPods.\n\"Assuming Apple prioritizes the iPhone 12 family, it probably affects iPads, Macs and older iPhones more,\" Fieldhack said.\nThe global chip shortage stems from a combination of factors including the fallout from last year's COVID-19 shutdowns and factories struggling to meet demand for semiconductors, which have become omnipresent in an increasingly digitized world.\nThe supply squeeze took the auto industry by surprise. Car makers like Ford Motor Co and General Motors Co had to halt production lines for their popular pick-ups at a time when demand was booming as economies started to open up.\nThe auto industry relies almost exclusively on chips from a few manufacturers, so-called foundries, including Taiwan Semiconductor Manufacturing Co (TSMC) and South Korea's Samsung Electronics Co Ltd. The shortage has exposed this reliance on overseas suppliers as an Achilles' heel for many companies.\nSTRATEGIC FOCUS\nTechnology companies, the traditional consumers of semiconductors, have been more nimble.\nChip designer Advanced Micro Devices, which makes central processor chips for PCs and data center servers, has also been redirecting supplies.\nThe company, which has a new family of chips that outperform offerings from larger rival Intel Corp, has steadily made gains in unit sales market share against the chip giant, which retains more than 80% of the overall market.\nAMD has responded to limited industry capacity by focusing on selling only its most profitable chips, leaving the lower end of the market to Intel, said Dean McCarron of Mercury Research, which tracks market share among chipmakers.\nIntel has also been struggling with its own set of challenges with manufacturing in recent years, causing it to fall behind AMD and Nvidia Corp.\n\"We're focusing on the most strategic segments of the PC market,\" AMD CEO Lisa Su told investors on a conference call.\n\"We believe that the data center business will continue to be a strong driver for us into the second half of the year.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":177148668,"gmtCreate":1627189720454,"gmtModify":1633767283161,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"How about Etsy? [疑问]&nbsp;[思考]&nbsp;","listText":"How about Etsy? [疑问]&nbsp;[思考]&nbsp;","text":"How about Etsy? [疑问] [思考]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/177148668","repostId":"2153878189","repostType":4,"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604887616,"gmtCreate":1639370780443,"gmtModify":1639370781295,"author":{"id":"4087949413245130","authorId":"4087949413245130","name":"HoSeyLiao48","avatar":"https://static.tigerbbs.com/8a9a7795aa16cbb122ca86630c428a3a","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;[Like]&nbsp;[Bless]&nbsp;[Miser]&nbsp;","listText":"[Allin]&nbsp;[USD]&nbsp;[Call]&nbsp;[Call]&nbsp;[Call]&nbsp;[Like]&nbsp;[Like]&nbsp;[Bless]&nbsp;[Miser]&nbsp;","text":"[Allin] [USD] [Call] [Call] [Call] [Like] [Like] [Bless] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604887616","repostId":"1175891189","repostType":2,"isVote":1,"tweetType":1,"viewCount":561,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}